var title_f31_39_32368="Cyclosporine: Drug information";
var content_f31_39_32368=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Cyclosporine: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <div class=\"block inc\" id=\"F12618467\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <p>",
"     Information for this drug is presented separately based upon the following methods of administration:",
"    </p>",
"   </div>",
"   <div class=\"sec_xr rmolist\" id=\"F12618468\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <ul xmlns=\"\">",
"     <li>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?14/26/14756?source=see_link\">",
"       Cyclosporine (ophthalmic): Drug information",
"      </a>",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?30/8/30858?source=see_link\">",
"       Cyclosporine (systemic): Drug information",
"      </a>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 9217 Version 28.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-200.215.4.194-6EBEB1F6CE-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f31_39_32368=[""].join("\n");
var outline_f31_39_32368=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   DRUG INFORMATION",
"   <br/>",
"   [by method of administration]",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?14/26/14756?source=related_link\">",
"      Cyclosporine (ophthalmic): Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?30/8/30858?source=related_link\">",
"      Cyclosporine (systemic): Drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f31_39_32369="Bacitracin, neomycin, polymyxin B, and pramoxine: Drug information";
var content_f31_39_32369=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"20\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Bacitracin, neomycin, polymyxin B, and pramoxine: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"mobipreview.htm?2/24/2436?source=see_link\">",
"    see \"Bacitracin, neomycin, polymyxin B, and pramoxine: Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F138848\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Neosporin&reg; + Pain Relief Ointment [OTC];",
"     </li>",
"     <li>",
"      Tri Biozene [OTC]",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F138854\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Antibiotic, Topical",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F138849\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Topical: Apply 1-3 times/day to infected areas; cover with sterile bandage if needed",
"    </p>",
"   </div>",
"   <div class=\"block dop drugH1Div\" id=\"F138853\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Pediatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Topical: Children &ge;2 years: Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F2558367\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F138843\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ointment, topical: Bacitracin 500 units, neomycin 3.5 mg, polymyxin B 10,000 units, and pramoxine hydrochloride 10 mg (15 g, 30 g)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Neosporin&reg; + Pain Relief Ointment: Bacitracin 500 units, neomycin 3.5 mg, polymyxin B 10,000 units, and pramoxine hydrochloride 10 mg per g (15 g, 30 g)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Tri Biozene: Bacitracin 500 units, neomycin 3.5 mg, polymyxin B 10,000 units, and pramoxine hydrochloride 10 mg per g (15 g)",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F138839\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F138844\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Prevention and treatment of susceptible superficial topical infections and provide temporary relief of pain or discomfort",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F138846\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to bacitracin, neomycin, polymyxin B, pramoxine, or any component of the formulation",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F138840\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Other warnings/precautions:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Appropriate use: For external use only; avoid in eyes. Not for use over large areas of the body or for longer than 1 week.",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 8681 Version 29.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0605-2.133.93.82-3DA446CC7F-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f31_39_32369=[""].join("\n");
var outline_f31_39_32369=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F138848\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F138854\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F138849\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F138853\">",
"      Dosing: Pediatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2558367\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F138843\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F138839\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F138844\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F138846\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F138840\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/8681\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/8681|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?2/24/2436?source=related_link\">",
"      Bacitracin, neomycin, polymyxin B, and pramoxine: Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f31_39_32370="Patient information: Hepatitis C (The Basics)";
var content_f31_39_32370=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div>",
"   &nbsp;",
"  </div>",
"  <div id=\"basicsTopicMinWidth\">",
"   <div id=\"basicsTopicRight\">",
"    <div id=\"placeholder\">",
"     <div id=\"basics-graphics\">",
"      <span class=\"basics-box-top\">",
"      </span>",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-graphics-title.png\"/>",
"       <span class=\"openRelatedGraphics\" id=\"PI/15381\" rel=\"graphic_box\">",
"        <a href=\"#\" title=\"View All Related Graphics\">",
"         View All",
"        </a>",
"       </span>",
"      </h4>",
"      <ul>",
"       <li>",
"        <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?39/54/40804\">",
"         Organs inside the abdomen (belly)",
"        </a>",
"       </li>",
"      </ul>",
"      <a href=\"#\" id=\"basics-seeall\">",
"       See All Graphics",
"      </a>",
"     </div>",
"     <script type=\"text/javascript\">",
"      if ($(\"#basics-graphics li\").length &lt;= 4) {",
"				$(\"#basics-seeall\").remove();",
"			} else {",
"				$(\"#basics-graphics li:gt(3)\").addClass(\"hidden\");",
"				$(\"#basics-seeall\").click(function(){",
"					$(\"#basics-graphics li.hidden\").removeClass(\"hidden\");",
"					$(this).remove();",
"					return false;",
"				});",
"			}",
"     </script>",
"     <div class=\"ieSpacer\">",
"     </div>",
"     <div id=\"basics-more\">",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-more-title.png\"/>",
"      </h4>",
"      <dl>",
"       <dt class=\"basics\">",
"        The Basics",
"       </dt>",
"       <dd>",
"        <a href=\"mobipreview.htm?38/28/39361\">",
"         Patient information: Alcohol use &mdash; when is drinking a problem? (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?24/25/24979\">",
"         Patient information: Cirrhosis (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?25/41/26258\">",
"         Patient information: Hepatitis B (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?4/22/4451\">",
"         Patient information: Latest medicines for hepatitis C (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?24/34/25122\">",
"         Patient information: Liver transplant (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?29/35/30258\">",
"         Patient information: Treatment for hepatitis C (The Basics)",
"        </a>",
"       </dd>",
"       <dt class=\"beyondthebasics\">",
"        Beyond the Basics",
"       </dt>",
"       <dd>",
"        <a href=\"mobipreview.htm?17/4/17478\">",
"         Patient information: Hepatitis C (Beyond the Basics)",
"        </a>",
"       </dd>",
"      </dl>",
"      <div id=\"tooltipper\">",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"   <div id=\"basicsTopicLeft\">",
"    <div id=\"topicTitle\">",
"     Patient information: Hepatitis C (The Basics)",
"    </div>",
"    <span class=\"view\">",
"     View in",
"     <a class=\"lang\" href=\"./es-419/hepatitis-c-the-basics?source=topic_page\">",
"      Spanish",
"     </a>",
"    </span>",
"    <a class=\"contributor contributor_credentials\" href=\"./authors-and-editors/patient-information\">",
"     Written by the doctors and editors at UpToDate",
"    </a>",
"    <div id=\"topicText\">",
"     <p class=\"headingAnchor\" id=\"H459780793\">",
"      <span class=\"h1\">",
"       What is hepatitis C?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Hepatitis C is a disease that harms the liver. The liver is a big organ in the upper right side of the belly (",
"      <a class=\"graphic graphic_figure graphicRef64960 \" href=\"mobipreview.htm?39/54/40804\">",
"       figure 1",
"      </a>",
"      ). A virus causes this disease. The virus spreads from person to person through contact with blood. This can happen in a few ways, like sharing drug needles or having sex.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H459780800\">",
"      <span class=\"h1\">",
"       What are the symptoms of hepatitis C?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Most people with hepatitis C have no symptoms. When symptoms do occur, they can include:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Feeling tired or weak",
"       </li>",
"       <li>",
"        Lack of hunger",
"       </li>",
"       <li>",
"        Nausea",
"       </li>",
"       <li>",
"        Muscle or joint aches",
"       </li>",
"       <li>",
"        Weight loss",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      In most cases, hepatitis C lasts for many years. That can lead to liver scarring, called &ldquo;cirrhosis.&rdquo; Symptoms of cirrhosis include:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Swelling in the belly and legs, and fluid build-up in the lungs",
"       </li>",
"       <li>",
"        Bruising or bleeding easily",
"       </li>",
"       <li>",
"        Trouble taking in a full breath",
"       </li>",
"       <li>",
"        Feeling full in the belly",
"       </li>",
"       <li>",
"        Confusion that can come on suddenly",
"       </li>",
"       <li>",
"        Coma",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H459780807\">",
"      <span class=\"h1\">",
"       How did I get the disease?",
"      </span>",
"      &nbsp;&mdash;&nbsp;You can catch the hepatitis C virus if you have contact with the blood of someone who is infected. This can happen if you:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Share drug needles or cocaine straws",
"       </li>",
"       <li>",
"        Have sex with someone who is infected",
"       </li>",
"       <li>",
"        Use infected needles for tattooing, acupuncture, or piercings",
"       </li>",
"       <li>",
"        Share toothbrushes, razors, or other things that could have blood on them",
"       </li>",
"       <li>",
"        Got a blood transfusion before 1990 (when the way blood was handled changed)",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      A pregnant woman who is infected can also give hepatitis C to her baby.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H459780814\">",
"      <span class=\"h1\">",
"       Is there a test for hepatitis C?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Yes. Your doctor might order a few tests:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Blood tests can show:",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      <ul class=\"hyphen-block\">",
"       <li>",
"        If you have hepatitis C",
"       </li>",
"       <li>",
"        What type of the virus you have (there are 4 types)",
"       </li>",
"       <li>",
"        Which treatment will work best for you",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Biopsy &mdash; In this test, a doctor puts a needle into your liver and takes out a small sample of tissue. The sample will show how bad the damage is.",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H459780821\">",
"      <span class=\"h1\">",
"       How is hepatitis C treated?",
"      </span>",
"      &nbsp;&mdash;&nbsp;It depends on what type of hepatitis C you have. For most patients, treatments include 2 main medicines that fight the virus. One comes as a pill. The other is a shot. Most people must take both of these medicines. Treatment usually lasts 6 months to a year.",
"     </p>",
"     <p>",
"      People with type 1 can also get a second pill to take. The second pill could be",
"      <a class=\"drug drug_patient\" href=\"mobipreview.htm?20/1/20501?source=see_link\">",
"       boceprevir",
"      </a>",
"      (brand name: Victrelis",
"      <sup>",
"       TM",
"      </sup>",
"      ) or",
"      <a class=\"drug drug_patient\" href=\"mobipreview.htm?24/19/24885?source=see_link\">",
"       telaprevir",
"      </a>",
"      (brand name: Incivek",
"      <sup>",
"       TM",
"      </sup>",
"      ). Either one of these medicines greatly increases the chances that a person will be cured. But both medicines work only on type 1.",
"     </p>",
"     <p>",
"      Some people should not take the medicines used to treat hepatitis C, including:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Pregnant women",
"       </li>",
"       <li>",
"        Women who are trying to get pregnant or who are not using a reliable form of birth control",
"       </li>",
"       <li>",
"        Men who are trying to get someone pregnant or who are not using a reliable form of birth control",
"       </li>",
"       <li>",
"        People with depression and other medical conditions",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      Your doctor can help you decide if these medicines are right for you.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H459780828\">",
"      <span class=\"h1\">",
"       Is there anything I can do to protect my liver?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Yes, you can:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Avoid alcohol.",
"       </li>",
"       <li>",
"        Get vaccinated for hepatitis A and B.",
"       </li>",
"       <li>",
"        Get vaccinated for pneumonia, the flu, and other diseases.",
"       </li>",
"       <li>",
"        Ask your doctor or nurse before taking any over-the-counter pain medicines (these medicines can sometimes damage the liver).",
"       </li>",
"       <li>",
"        Avoid marijuana.",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H459780835\">",
"      <span class=\"h1\">",
"       What if I want to get pregnant?",
"      </span>",
"      &nbsp;&mdash;&nbsp;If you want to get pregnant, talk to your doctor or nurse first. About 1 in 20 women who have hepatitis C pass the virus on to the baby during pregnancy. That number goes up in women who are also infected with HIV.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H459780842\">",
"      <span class=\"h1\">",
"       What will my life be like?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Many people with hepatitis C are able to live normal lives. Treatment can cure the disease in many cases. Scientists are also working on new treatments.",
"     </p>",
"     <p>",
"      If you have hepatitis C, it is still safe to:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Hug, kiss, and touch other people (but you can spread the infection through sex)",
"       </li>",
"       <li>",
"        Share forks, spoons, cups, and food",
"       </li>",
"       <li>",
"        Sneeze or cough",
"       </li>",
"       <li>",
"        Breastfeed",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H459780849\">",
"      <span class=\"h1\">",
"       More on this topic",
"      </span>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?4/22/4451?source=see_link\">",
"       Patient information: Latest medicines for hepatitis C (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?38/28/39361?source=see_link\">",
"       Patient information: Alcohol use &mdash; when is drinking a problem? (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?25/41/26258?source=see_link\">",
"       Patient information: Hepatitis B (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?24/25/24979?source=see_link\">",
"       Patient information: Cirrhosis (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?29/35/30258?source=see_link\">",
"       Patient information: Treatment for hepatitis C (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?24/34/25122?source=see_link\">",
"       Patient information: Liver transplant (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?17/4/17478?source=see_link\">",
"       Patient information: Hepatitis C (Beyond the Basics)",
"      </a>",
"     </p>",
"    </div>",
"    <div id=\"reviewProcess\">",
"     <span>",
"      All topics are updated as new evidence becomes available and our",
"      <a class=\"policy policy_editorialpolicy\" href=\"/home/editorial-policy\">",
"       peer review process",
"      </a>",
"      is complete.",
"     </span>",
"    </div>",
"    <div id=\"topicRetrievedDate\">",
"     <span class=\"emphasis\">",
"      This topic retrieved from UpToDate on:",
"     </span>",
"     Apr 14, 2013.",
"    </div>",
"    <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"     <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"      Find",
"     </a>",
"     <a class=\"toolbutton printicon\" href=\"mobipreview.htm?31/39/32370?view=print\" title=\"Print This Topic\">",
"      Print",
"     </a>",
"     <a class=\"toolbutton emailicon etacLink\" href=\"#\" title=\"Email This Topic\">",
"      Email",
"     </a>",
"    </div>",
"    <div id=\"disclaimer\">",
"     The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions.",
"The use of UpToDate content is governed by the",
"     <a class=\"legal legal_termsofuse\" href=\"/home/terms-use\" target=\"_blank\">",
"      UpToDate Terms of Use",
"     </a>",
"     . &copy;2013 UpToDate, Inc. All rights reserved.",
"    </div>",
"    <div id=\"topicVersionRevision\">",
"     Topic 15381 Version 5.0",
"    </div>",
"   </div>",
"   <!--  basicsTopicLeft -->",
"  </div>",
"  <!-- basicsTopicMinWidth -->",
" </div>",
" <!-- topicContent -->",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0605-188.40.116.55-6D8648E745-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f31_39_32370=[""].join("\n");
var outline_f31_39_32370=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H459780793\">",
"      What is hepatitis C?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H459780800\">",
"      What are the symptoms of hepatitis C?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H459780807\">",
"      How did I get the disease?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H459780814\">",
"      Is there a test for hepatitis C?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H459780821\">",
"      How is hepatitis C treated?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H459780828\">",
"      Is there anything I can do to protect my liver?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H459780835\">",
"      What if I want to get pregnant?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H459780842\">",
"      What will my life be like?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H459780849\">",
"      More on this topic",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PI/15381\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li>",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?39/54/40804\">",
"      Organs inside the abdomen (belly)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?38/28/39361?source=related_link\">",
"      Patient information: Alcohol use &mdash; when is drinking a problem? (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?24/25/24979?source=related_link\">",
"      Patient information: Cirrhosis (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?25/41/26258?source=related_link\">",
"      Patient information: Hepatitis B (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?17/4/17478?source=related_link\">",
"      Patient information: Hepatitis C (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?4/22/4451?source=related_link\">",
"      Patient information: Latest medicines for hepatitis C (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?24/34/25122?source=related_link\">",
"      Patient information: Liver transplant (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?29/35/30258?source=related_link\">",
"      Patient information: Treatment for hepatitis C (The Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f31_39_32371="Acute cutaneous lupus erythematosus - malar";
var content_f31_39_32371=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F75781&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F75781&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Acute cutaneous lupus erythematosus",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Malar erythema and subtle edema are present in this patient with systemic lupus erythematosus.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f31_39_32371=[""].join("\n");
var outline_f31_39_32371=null;
var title_f31_39_32372="Rectal leiomyoma Light";
var content_f31_39_32372=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F61429&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F61429&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Rectal leiomyoma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 433px; height: 288px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Low power view of a rectal leiomyoma. There is expansion of the submucosa by homogeneous, eosinophilc cells arranged in sheets.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Robert Odze, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f31_39_32372=[""].join("\n");
var outline_f31_39_32372=null;
var title_f31_39_32373="Histopath bronchogenic cyst";
var content_f31_39_32373=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F52817&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F52817&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Histopathology of a bronchogenic cyst",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 288px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The wall of the cyst has features of respiratory epithelium and contains cartilage and smooth muscle typical of a bronchus. The finding of cartilage plates is essential for the diagnosis.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Christopher Oermann, MD and Claire Langston, MD",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f31_39_32373=[""].join("\n");
var outline_f31_39_32373=null;
var title_f31_39_32374="Direct laryngoscopy straight blade";
var content_f31_39_32374=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F77129&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F77129&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 474px\">",
"   <div class=\"ttl\">",
"    Direct laryngoscopy with a straight blade",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 454px; height: 608px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Direct laryngoscopy using a straight blade.",
"    <br>",
"     (A) The head is positioned with the right hand, and the mouth is opened using the fifth finger of the left hand (if necessary).",
"     <br>",
"      (B) Alternately, the mouth may be opened with the thumb and index finger of the right hand using a \"scissor\" technique.",
"      <br>",
"       (C) The laryngoscope blade is inserted under direct vision over the tongue and into the vallecula. One attempt may be made at this point to elevate the epiglottis by lifting upward on the laryngoscope handle at a 45-degree angle.",
"       <br>",
"        (D) If unsuccessful, the tip of the blade is used to directly retract the epiglottis, revealing the vocal cords and glottic opening.",
"        <div class=\"footnotes\">",
"        </div>",
"        <div class=\"reference\">",
"         Reproduced with permission from: King C, Rappaport LD. Emergent endotracheal intubation. In: Textbook of Pediatric Emergency Procedures, 2nd ed, King C, Henretig FM (Eds), Lippincott Williams &amp; Wilkins, Philadelphia 2008. Copyright &copy; 2008 Lippincott Williams &amp; Wilkins.",
"        </div>",
"        <div class=\"contractual\">",
"         <br/>",
"         <a href=\"file://www.lww.com\">",
"          file://www.lww.com",
"         </a>",
"        </div>",
"       </br>",
"      </br>",
"     </br>",
"    </br>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f31_39_32374=[""].join("\n");
var outline_f31_39_32374=null;
var title_f31_39_32375="Scopolamine (systemic): Drug information";
var content_f31_39_32375=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Scopolamine (systemic): Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"mobipreview.htm?10/12/10437?source=see_link\">",
"    see \"Scopolamine (systemic): Patient drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?39/0/39941?source=see_link\">",
"    see \"Scopolamine (systemic): Pediatric drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F9522574\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Transderm Sc��p&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F9522575\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Buscopan&reg;;",
"     </li>",
"     <li>",
"      Scopolamine Hydrobromide Injection;",
"     </li>",
"     <li>",
"      Transderm-V&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F9523602\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Anticholinergic Agent",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F9522653\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Note:",
"     </b>",
"     Scopolamine (hyoscine) hydrobromide should not be interchanged with scopolamine butylbromide formulations. Dosages are not equivalent.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:0em;text-align:justify;\">",
"     <b>",
"      Scopolamine base:",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <i>",
"      Preoperative:",
"     </i>",
"     Transdermal patch: Apply 1 patch to hairless area behind ear the night before surgery or 1 hour prior to cesarean section (apply no sooner than 1 hour before surgery to minimize newborn exposure); remove 24 hours after surgery",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <i>",
"      Motion sickness:",
"     </i>",
"     Transdermal patch: Apply 1 patch to hairless area behind the ear at least 4 hours prior to exposure and every 3 days as needed; effective if applied as soon as 2-3 hours before anticipated need, best if 12 hours before",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <i>",
"      Chemotherapy-induced nausea and vomiting, breakthrough (unlabeled use):",
"     </i>",
"     Apply 1 patch every 72 hours (NCCN Antiemesis guidelines v.1.2012)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Scopolamine hydrobromide:",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <i>",
"      Antiemetic:",
"     </i>",
"     SubQ: 0.6-1 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <i>",
"      Preoperative:",
"     </i>",
"     I.M., I.V., SubQ: 0.3-0.65 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <i>",
"      Sedation, tranquilization:",
"     </i>",
"     I.M., I.V., SubQ:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     U.S. labeling: 0.6 mg 3-4 times/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Canadian labeling: 0.3-0.6 mg 3-4 times/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:0em;text-align:justify;\">",
"     <b>",
"      Scopolamine butylbromide:",
"     </b>",
"     <i>",
"      Gastrointestinal/genitourinary spasm",
"     </i>",
"     (Buscopan&reg; [CAN]; not available in the U.S.):",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Oral: Acute therapy: 10-20 mg daily (1-2 tablets); prolonged therapy: 10 mg (1 tablet) 3-5 times/day; maximum: 60 mg/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     I.M., I.V., SubQ: 10-20 mg; maximum: 100 mg/day",
"    </p>",
"   </div>",
"   <div class=\"block dop drugH1Div\" id=\"F9522652\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Pediatric",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?39/0/39941?source=see_link\">",
"      see \"Scopolamine (systemic): Pediatric drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     <b>",
"      Scopolamine hydrobromide:",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <i>",
"      Antiemetic:",
"     </i>",
"     SubQ: 0.006 mg/kg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <i>",
"      Preoperative:",
"     </i>",
"     I.M., I.V., SubQ:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Children 6 months to 3 years: 0.1-0.15 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Children 3-6 years: 0.2-0.3 mg",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F9522654\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Lower dosages may be required. Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block dor drugH1Div\" id=\"F13853959\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Renal Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     There are no dosage adjustments in the manufacturer labeling; however, caution is recommended due to increased risks of adverse effects.",
"    </p>",
"   </div>",
"   <div class=\"block doh drugH1Div\" id=\"F13853958\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Hepatic Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     There are no dosage adjustments in the manufacturer labeling; however, caution is recommended due to increased risks of adverse effects.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F9522694\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Injection, solution, as hydrobromide: 0.4 mg/mL (1 mL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Patch, transdermal:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Transderm Sc��p&reg;: 1.5 mg (4s, 10s, 24s) [contains metal; releases ~1 mg over 72 hours]",
"    </p>",
"   </div>",
"   <div class=\"block foccan drugH1Div\" id=\"F13854240\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: Canada",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Tablet, oral, as butylbromide:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Buscopan&reg;: 10 mg",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F9522579\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes: Injection",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F9522660\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Note:",
"     </b>",
"     Butylbromide or hydrobromide may be administered by I.M., I.V., or SubQ injection.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     I.M.:",
"     <b>",
"      Butylbromide:",
"     </b>",
"     Intramuscular injections should be administered 10-15 minutes prior to radiological/diagnostic procedures.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     I.V.:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <b>",
"      Butylbromide:",
"     </b>",
"     No dilution is necessary prior to injection; inject at a rate of 1 mL/minute",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <b>",
"      Hydrobromide:",
"     </b>",
"     Dilute with an equal volume of sterile water and administer by direct I.V.; inject over 2-3 minutes",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Oral: Tablet should be swallowed whole and taken with a full glass of water.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Transdermal: Apply to hairless area of skin behind the ear. Wash hands before and after applying the disc to avoid drug contact with eyes. Do not use any patch that has been damaged, cut, or manipulated in any way. Topical patch is programmed to deliver 1 mg over 3 days. Once applied, do not remove the patch for 3 full days (motion sickness). When used postoperatively for nausea/vomiting, the patch should be removed 24 hours after surgery. If patch becomes displaced, discard and apply a new patch.",
"    </p>",
"   </div>",
"   <div class=\"block scp drugH1Div\" id=\"F9522627\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Compatibility",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Butylbromide injection: Stable in D",
"     <sub>",
"      5",
"     </sub>",
"     W, NS, D",
"     <sub>",
"      10",
"     </sub>",
"     W, LR, Ringer's solution.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Hydrobromide injection: Avoid acid solutions.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;text-align:justify;\">",
"     <b>",
"      Y-site administration: Hydrobromide: Compatible:",
"     </b>",
"     Fentanyl, heparin, hydrocortisone sodium succinate, hydromorphone, methadone, morphine, potassium chloride, propofol, sufentanil, vitamin B complex with C.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Compatibility in syringe:",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <b>",
"      Hydrobromide: Compatible:",
"     </b>",
"     Atropine, butorphanol, chlorpromazine, cimetidine, dimenhydrinate, diphenhydramine, droperidol, fentanyl, glycopyrrolate, hydromorphone, hydroxyzine, meperidine, methotrimeprazine, metoclopramide, midazolam, morphine, nalbuphine, pentazocine, pentobarbital, prochlorperazine edisylate, promethazine, ranitidine, sufentanil, thiopental.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <b>",
"      Butylbromide: Compatible:",
"     </b>",
"     Dimenhydrinate.",
"     <b>",
"      Variable (consult detailed reference):",
"     </b>",
"     Haloperidol.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F9522580\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Scopolamine base:",
"     </b>",
"     Transdermal: Prevention of nausea/vomiting associated with motion sickness and recovery from anesthesia and surgery",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:0em;text-align:justify;\">",
"     <b>",
"      Scopolamine hydrobromide:",
"     </b>",
"     Injection: Preoperative medication to produce amnesia, sedation, tranquilization, antiemetic effects, and decrease salivary and respiratory secretions",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:0em;text-align:justify;\">",
"     <b>",
"      Scopolamine butylbromide [not available in the U.S.]:",
"     </b>",
"     Oral/injection: Treatment of smooth muscle spasm of the genitourinary or gastrointestinal tract; injection may also be used prior to radiological/diagnostic procedures to prevent spasm",
"    </p>",
"   </div>",
"   <div class=\"block usu drugH1Div\" id=\"F13166585\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use - Unlabeled",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Scopolamine base: Transdermal:",
"     </b>",
"     Breakthrough treatment of nausea and vomiting associated with chemotherapy",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F9522566\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      BEERS Criteria medication:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       This drug may be potentially inappropriate for use in geriatric patients (Quality of evidence - moderate; Strength of recommendation - strong).",
"      </p>",
"     </div>",
"    </div>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Other safety concerns:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       Transdermal patch may contain conducting metal (eg, aluminum); remove patch prior to MRI.",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F9522599\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Frequency not defined.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Cardiovascular: Bradycardia, flushing, orthostatic hypotension, tachycardia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Central nervous system: Acute toxic psychosis (rare), agitation (rare), ataxia, confusion, delusion (rare), disorientation, dizziness, drowsiness, fatigue, hallucination (rare), headache, irritability, loss of memory, paranoid behavior (rare), restlessness, sedation",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Dermatologic: Drug eruptions, dry skin, dyshidrosis, erythema, pruritus, rash, urticaria",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Endocrine &amp; metabolic: Thirst",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Gastrointestinal: Constipation, diarrhea, dry throat, dysphagia, nausea, vomiting, xerostomia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Genitourinary: Dysuria, urinary retention",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Neuromuscular &amp; skeletal: Tremor, weakness",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Ocular: Accommodation impaired, blurred vision, conjunctival infection, cycloplegia, dryness, glaucoma (narrow-angle), increased intraocular pain, itching, photophobia, pupil dilation, retinal pigmentation",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Respiratory: Dry nose, dyspnea",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Miscellaneous: Anaphylaxis (rare), anaphylactic shock (rare), angioedema, diaphoresis decreased, heat intolerance, hypersensitivity reactions",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F9522592\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Transdermal, oral: Hypersensitivity to scopolamine, other belladonna alkaloids, or any component of the formulation; narrow-angle glaucoma",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Injection: Hypersensitivity to scopolamine, other belladonna alkaloids, or any component of the formulation; narrow-angle glaucoma; chronic lung disease (repeated administration)",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     Canadian labeling: Additional contraindications (not in U.S. labeling):",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Oral: Glaucoma, megacolon, myasthenia gravis, obstructive prostatic hypertrophy",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Injection:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     Hyoscine butylbromide:  Untreated narrow-angle glaucoma; megacolon, prostatic hypertrophy with urinary retention; stenotic lesions of the GI tract; myasthenia gravis; tachycardia, angina, or heart failure; I.M. administration in patients receiving anticoagulant therapy",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     Scopolamine hydrobromide: Glaucoma or predisposition to narrow-angle glaucoma; paralytic ileus; prostatic hypertrophy; pyloric obstruction; tachycardia secondary to cardiac insufficiency or thyrotoxicosis",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F9522593\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concerns related to adverse effects:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Anaphylaxis: Anaphylaxis including episodes of shock has been reported following parenteral administration; observe for signs/symptoms of hypersensitivity following parenteral administration. Patients with a history of allergies or asthma may be at increased risk of hypersensitivity reactions.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; CNS effects: May cause drowsiness and/or blurred vision, which may impair physical or mental abilities; patients must be cautioned about performing tasks which require mental alertness (eg, operating machinery or driving).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Idiosyncratic reaction: Idiosyncratic reactions may rarely occur; patients may experience acute toxic psychosis, agitation, confusion, delusions, hallucinations, paranoid behavior, and rambling speech.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Visual disturbances: Discontinue if patient reports unusual visual disturbances or pain within the eye.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Withdrawal: Adverse events (including dizziness, headache, nausea, vomiting) may occur following abrupt discontinuation of large doses or in patients with Parkinson&rsquo;s disease; adverse events may also occur following removal of the transdermal patch although symptoms may not appear until &ge;24 hours after removal.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Disease-related concerns:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Cardiovascular disease: Use with caution in patients with coronary artery disease, tachyarrhythmias, heart failure, or hypertension; evaluate tachycardia prior to administration.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Gastrointestinal (GI) obstruction: Use with caution in patients with GI obstruction;  when used for the treatment of smooth muscle spasm of the GI tract avoid continuous (daily) or prolonged use without evaluating source of abdominal pain. Patients should be instructed to report persistent or worsening abdominal pain with or without other symptoms (eg, nausea/vomiting, irregular bowel movements, bloody stool, hypotension).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Genitourinary (GU) disease/obstruction: Use with caution in patients with GU obstruction, prostatic hyperplasia, or urinary retention;  when used for the treatment of smooth muscle spasm of the GU tract avoid continuous (daily) or prolonged use without evaluating source of the spasm.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Glaucoma: Use of the transdermal product in patients with open-angle glaucoma may necessitate adjustments in glaucoma therapy.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hepatic impairment: Use with caution in patients with hepatic impairment; adverse CNS effects occur more often in these patients.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hiatal hernia: Use with caution in patients with hiatal hernia with reflux esophagitis.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hyperthyroidism: Use caution in patients with hyperthyroidism; may have increased risk for arrhythmias.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Psychosis: Use with caution in patients with a history of psychosis; may exacerbate condition.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Renal impairment: Use with caution in patients with renal impairment; adverse CNS effects occur more often in these patients.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Seizure disorders: Use with caution in patients with a history of seizure disorder; may exacerbate condition.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Ulcerative colitis: Use with caution in patients with ulcerative colitis; may precipitate/aggravate toxic megacolon.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Special populations:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Elderly: Avoid use in this age group due to potent anticholinergic adverse effects and uncertain effectiveness (Beers Criteria).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Pediatrics: Use with caution in infants and children since they may be more susceptible to adverse effects; safety and efficacy have not been established for the use of transdermal and oral scopolamine in children.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Dosage form specific issues:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Fructose: Tablets may contain sucrose; avoid use of tablets in patients who are fructose intolerant.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Product interchangeability: Scopolamine (hyoscine) hydrobromide should not be interchanged with scopolamine butylbromide formulations; dosages are not equivalent.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Transdermal patch: May contain conducting metal (eg, aluminum); remove patch prior to MRI.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13300031\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F9522602\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     AbobotulinumtoxinA: Anticholinergic Agents may enhance the anticholinergic effect of AbobotulinumtoxinA.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Acetylcholinesterase Inhibitors (Central): Anticholinergics may diminish the therapeutic effect of Acetylcholinesterase Inhibitors (Central). Acetylcholinesterase Inhibitors (Central) may diminish the therapeutic effect of Anticholinergics. If the anticholinergic action is a side effect of the agent, the result may be beneficial.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Aclidinium: May enhance the anticholinergic effect of Anticholinergics.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Alcohol (Ethyl): CNS Depressants may enhance the CNS depressant effect of Alcohol (Ethyl).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Anticholinergics: May enhance the adverse/toxic effect of other Anticholinergics.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Levocabastine (Nasal).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Azelastine (Nasal): CNS Depressants may enhance the CNS depressant effect of Azelastine (Nasal).",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Buprenorphine: CNS Depressants may enhance the CNS depressant effect of Buprenorphine.  Management: Consider reduced doses of CNS depressants used in combination with buprenorphine.  Consider avoiding other CNS depressants in patients thought to be at high risk of buprenorphine overuse or self-injection.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Cannabinoids: Anticholinergic Agents may enhance the tachycardic effect of Cannabinoids.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CNS Depressants: May enhance the adverse/toxic effect of other CNS Depressants.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Levocabastine (Nasal).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Droperidol: May enhance the CNS depressant effect of CNS Depressants. Management: Consider dose reductions of droperidol or of other CNS agents (e.g., opioids, barbiturates) with concomitant use.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     HydrOXYzine: May enhance the CNS depressant effect of CNS Depressants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ipratropium (Oral Inhalation): May enhance the anticholinergic effect of Anticholinergics.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Magnesium Sulfate: May enhance the CNS depressant effect of CNS Depressants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Methotrimeprazine: CNS Depressants may enhance the CNS depressant effect of Methotrimeprazine. Methotrimeprazine may enhance the CNS depressant effect of CNS Depressants.  Management: Reduce adult dose of CNS depressant agents by 50% with initiation of concomitant methotrimeprazine therapy. Further CNS depressant dosage adjustments should be initiated only after clinically effective methotrimeprazine dose is established.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Metyrosine: CNS Depressants may enhance the sedative effect of Metyrosine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Mirabegron: Anticholinergic Agents may enhance the therapeutic effect of Mirabegron. This may result in acute urinary retention.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Mirtazapine: CNS Depressants may enhance the CNS depressant effect of Mirtazapine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     OnabotulinumtoxinA: Anticholinergic Agents may enhance the anticholinergic effect of OnabotulinumtoxinA.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Paraldehyde: CNS Depressants may enhance the CNS depressant effect of Paraldehyde.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Perampanel: May enhance the CNS depressant effect of CNS Depressants. Management: Patients taking perampanel with any other drug that has CNS depressant activities should avoid complex and high-risk activities, particularly those such as driving that require alertness and coordination, until they have experience using the combination.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Potassium Chloride: Anticholinergic Agents may enhance the ulcerogenic effect of Potassium Chloride.  Management: Patients on drugs with substantial anticholinergic effects should avoid using any solid oral dosage form of potassium chloride.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pramipexole: CNS Depressants may enhance the sedative effect of Pramipexole.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pramlintide: May enhance the anticholinergic effect of Anticholinergics. These effects are specific to the GI tract.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     RimabotulinumtoxinB: Anticholinergic Agents may enhance the anticholinergic effect of RimabotulinumtoxinB.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     ROPINIRole: CNS Depressants may enhance the sedative effect of ROPINIRole.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Rotigotine: CNS Depressants may enhance the sedative effect of Rotigotine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Secretin: Anticholinergic Agents may diminish the therapeutic effect of Secretin.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Selective Serotonin Reuptake Inhibitors: CNS Depressants may enhance the adverse/toxic effect of Selective Serotonin Reuptake Inhibitors. Specifically, the risk of psychomotor impairment may be enhanced.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Sodium Oxybate: May enhance the CNS depressant effect of CNS Depressants. Management: Consider alternatives to combined use. When combined use is needed, consider minimizing doses of one or more drugs. Use of sodium oxybate with alcohol or sedative hypnotics is contraindicated.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tiotropium: Anticholinergics may enhance the anticholinergic effect of Tiotropium.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Topiramate: Anticholinergic Agents may enhance the adverse/toxic effect of Topiramate. Specifically, the risk of oligohidrosis and hyperthermia may be enhanced.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Zolpidem: CNS Depressants may enhance the CNS depressant effect of Zolpidem.  Management: Reduce the Intermezzo brand sublingual zolpidem dose to 1.75 mg for men who are also receiving other CNS depressants.  No such dose change is recommended for women.  Avoid use with other CNS depressants at bedtime; avoid use with alcohol.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block foi drugH1Div\" id=\"F9522606\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Ethanol/Nutrition/Herb Interactions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Ethanol: May increase CNS depression; monitor for increased effects with coadministration. Caution patients about effects.",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F9522581\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     C (",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F9522582\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Teratogenic effects were not observed in animal studies; embryotoxic events were observed in some studies. Scopolamine crosses the placenta; may cause respiratory depression and/or neonatal hemorrhage when used during pregnancy. Transdermal scopolamine has been used as an adjunct to epidural anesthesia for cesarean delivery without adverse CNS effects on the newborn. Parenteral administration does not increase the duration of labor or affect uterine contractions. Except when used prior to cesarean section, use during pregnancy only if the benefit to the mother outweighs the potential risk to the fetus.",
"    </p>",
"   </div>",
"   <div class=\"block lac drugH1Div\" id=\"F9522584\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Lactation",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Enters breast milk/use caution (AAP rates &ldquo;compatible&rdquo;; AAP 2001 update pending)",
"    </p>",
"   </div>",
"   <div class=\"block fee drugH1Div\" id=\"F9522697\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pricing: U.S. (Medi-Span&reg;)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Patch, 72-hour",
"     </b>",
"     (Transderm-Scop Transdermal)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     1.5 mg (4): $63.54",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Solution",
"     </b>",
"     (Scopolamine HBr Injection)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     0.4 mg/mL (1 mL): $9.54",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F9522664\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Body temperature, heart rate, urinary output, intraocular pressure",
"    </p>",
"   </div>",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F10962006\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Ariel TDDS (HK);",
"     </li>",
"     <li>",
"      Belloid (IN);",
"     </li>",
"     <li>",
"      Bupasmol (UY);",
"     </li>",
"     <li>",
"      Buscapina (AR, CN, CO, CR, GT, HN, NI, PA, PE, PY, SV, UY, VE);",
"     </li>",
"     <li>",
"      Buscopan (AT, BE, BR, CH, CZ, DK, FI, GB, GR, HK, IE, IN, IT, MY, PH, PK, PL, PT, RU, SE, SG, TH, TR, TW);",
"     </li>",
"     <li>",
"      Butyl (TH);",
"     </li>",
"     <li>",
"      Cifespasma (AR);",
"     </li>",
"     <li>",
"      Copan (HK, MY);",
"     </li>",
"     <li>",
"      Dhacopan (HK);",
"     </li>",
"     <li>",
"      Dormi (ID);",
"     </li>",
"     <li>",
"      Encodex (MY);",
"     </li>",
"     <li>",
"      Escapin (PE);",
"     </li>",
"     <li>",
"      Espasmotab (EC);",
"     </li>",
"     <li>",
"      Gastride (PH);",
"     </li>",
"     <li>",
"      Higan (TH);",
"     </li>",
"     <li>",
"      Hyomide (HK);",
"     </li>",
"     <li>",
"      Hyospasmol (ZA);",
"     </li>",
"     <li>",
"      Kimite Pad (CL);",
"     </li>",
"     <li>",
"      Kwells (IE);",
"     </li>",
"     <li>",
"      Labinpina (CO);",
"     </li>",
"     <li>",
"      Modul (PE);",
"     </li>",
"     <li>",
"      Scoburen (FR);",
"     </li>",
"     <li>",
"      Scobutrin (ID);",
"     </li>",
"     <li>",
"      Scolmin (PH);",
"     </li>",
"     <li>",
"      Scopamin (ID);",
"     </li>",
"     <li>",
"      Scopma (ID);",
"     </li>",
"     <li>",
"      Scopoderm (AT, DK, FI, GB, SE);",
"     </li>",
"     <li>",
"      Scopoderm TTS (FR, NL, NZ);",
"     </li>",
"     <li>",
"      Setacol (AU);",
"     </li>",
"     <li>",
"      Skopolamin (NO);",
"     </li>",
"     <li>",
"      Soonway (TW);",
"     </li>",
"     <li>",
"      Vacopan (MY, SG, TH)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F9522628\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Blocks the action of acetylcholine at parasympathetic sites in smooth muscle, secretory glands and the CNS; increases cardiac output, dries secretions, antagonizes histamine and serotonin",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F9522630\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Onset of action: Oral, I.M.: 0.5-1 hour; I.V.: 10 minutes; Transdermal: 6-8 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Duration: I.M., I.V., SubQ: 4 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Absorption: I.M., SubQ: Rapid; Oral: Quaternary salts (butylbromide) are poorly absorbed (local concentrations in the GI tract following oral dosing may be high)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Distribution: V",
"     <sub>",
"      d",
"     </sub>",
"     : Butylbromide: 128 L",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Protein binding: Butylbromide: ~4% (albumin)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Metabolism: Hepatic",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Bioavailability: Oral: 8%",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Half-life elimination: Butylbromide: ~5-11 hours; Hydrobromide: ~1-4 hours; Scopolamine base: 9.5 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Time to peak: Hydrobromide: I.M.: ~20 minutes, SubQ: ~15 minutes; Butylbromide: Oral: ~2 hours; Scopolamine base: Transdermal: 24 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Excretion: Urine (&lt;10%, as parent drug and metabolites); I.V.: Butylbromide: Urine (42% to 61% [half as parent drug]), feces (28% to 37%)",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      American Academy of Pediatrics Committee on Drugs, \"Transfer of Drugs and Other Chemicals Into Human Milk,\"",
"      <i>",
"       Pediatrics",
"      </i>",
"      , 2001, 108(3):776-89.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?31/39/32375/abstract-text/11533352/pubmed\" id=\"11533352\" target=\"_blank\">",
"        11533352",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      American Geriatrics Society 2012 Beers Criteria Update Expert Panel, \"American Geriatrics Society Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults,\"",
"      <i>",
"       J Am Geriatr Soc",
"      </i>",
"      , 2012, 60(4):616-31.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?31/39/32375/abstract-text/22376048/pubmed\" id=\"22376048\" target=\"_blank\">",
"        22376048",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Feinberg M, &ldquo;The Problems of Anticholinergic Adverse Effects in Older Patients,&rdquo;",
"      <i>",
"       Drugs Aging",
"      </i>",
"      , 1993, 3(4):335-48.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?31/39/32375/abstract-text/8369593/pubmed\" id=\"8369593\" target=\"_blank\">",
"        8369593",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Gan TJ, Sinha AC, Kovac AL, et al, &ldquo;A Randomized, Double-Blind, Multicenter Trial Comparing Transdermal Scopolamine Plus Ondansetron to Ondansetron Alone for the Prevention of Postoperative Nausea and Vomiting in the Outpatient Setting,&rdquo;",
"      <i>",
"       Anesth Analg",
"      </i>",
"      , 2009, 108(5):1498-504.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?31/39/32375/abstract-text/19372328/pubmed\" id=\"19372328\" target=\"_blank\">",
"        19372328",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      National Comprehensive Cancer Network&reg; (NCCN), &ldquo;Clinical Practice Guidelines in Oncology&trade;: Antiemesis,&rdquo; Version 1.2012. Available at file://www.nccn.org/professionals/physician_gls/PDF/antiemesis.pdf",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Renner UD, Oertel R, and Kirch W, &ldquo;Pharmacokinetics and Pharmacodynamics in Clinical Use of Scopolamine,&rdquo;",
"      <i>",
"       Ther Drug Monit",
"      </i>",
"      , 2005, 27(5):655-65.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?31/39/32375/abstract-text/16175141/pubmed\" id=\"16175141\" target=\"_blank\">",
"        16175141",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Sah N, Ramesh V, Kaul B, et al, &ldquo;Transdermal Scopolamine Patch in Addition to Ondansetron for Postoperative Nausea and Vomiting Prophylaxis in Patients Undergoing Ambulatory Cosmetic Surgery,&rdquo;",
"      <i>",
"       J Clin Anesth",
"      </i>",
"      , 2009, 21(4):249-52.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?31/39/32375/abstract-text/19502023/pubmed\" id=\"19502023\" target=\"_blank\">",
"        19502023",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Tytgat GN, &ldquo;Hyoscine Butylbromide: A Review of Its Use in the Treatment of Abdominal Cramping and Pain,&rdquo;",
"      <i>",
"       Drugs",
"      </i>",
"      , 2007, 67(9):1343-57.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?31/39/32375/abstract-text/17547475/pubmed\" id=\"17547475\" target=\"_blank\">",
"        17547475",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 9915 Version 43.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0603-189.41.172.26-18D72DAC39-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f31_39_32375=[""].join("\n");
var outline_f31_39_32375=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9522574\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9522575\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9523602\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9522653\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9522652\">",
"      Dosing: Pediatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9522654\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13853959\">",
"      Dosing: Renal Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13853958\">",
"      Dosing: Hepatic Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9522694\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13854240\">",
"      Dosage Forms: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9522579\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9522660\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9522627\">",
"      Compatibility",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9522580\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13166585\">",
"      Use - Unlabeled",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9522566\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9522599\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9522592\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9522593\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13300031\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9522602\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9522606\">",
"      Ethanol/Nutrition/Herb Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9522581\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9522582\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9522584\">",
"      Lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9522697\">",
"      Pricing: U.S. (Medi-Span&reg;)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9522664\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10962006\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9522628\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9522630\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9915\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9915|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?23/58/24484?source=related_link\">",
"      Scopolamine (ophthalmic): Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?4/8/4228?source=related_link\">",
"      Scopolamine (ophthalmic): Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?8/56/9092?source=related_link\">",
"      Scopolamine (ophthalmic): Pediatric drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?10/12/10437?source=related_link\">",
"      Scopolamine (systemic): Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?39/0/39941?source=related_link\">",
"      Scopolamine (systemic): Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f31_39_32376="Causes of scrotal pain in children and adolescents";
var content_f31_39_32376=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Causes of scrotal pain in children and adolescents",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?31/39/32376/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?31/39/32376/contributors\">",
"     Joel S Brenner, MD, MPH",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?31/39/32376/contributors\">",
"     Aderonke Ojo, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?31/39/32376/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?31/39/32376/contributors\">",
"     Amy B Middleman, MD, MPH, MS Ed",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?31/39/32376/contributors\">",
"     Gary R Fleisher, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?31/39/32376/contributors\">",
"     Laurence S Baskin, MD, FAAP",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?31/39/32376/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?31/39/32376/contributors\">",
"     James F Wiley, II, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?31/39/32376/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jun 14, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The spectrum of conditions that affect the scrotum and its contents ranges from incidental findings to pathologic events that require expeditious diagnosis and treatment (eg, testicular torsion, testicular cancer). The most common causes of acute scrotal pain in children and adolescents include testicular torsion, torsion of the appendix testis, and epididymitis. In one review of 238 consecutive boys, ages 0 to 19 years, who presented with acute scrotal pain to a children's hospital over a two-year period, 16 percent had testicular torsion, 46 percent had torsion of the appendix testis, and 35 percent had epididymitis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32376/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The causes of scrotal pain will be reviewed here. The evaluation scrotal pain or swelling and causes of scrotal swelling are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?2/38/2663?source=see_link\">",
"     \"Evaluation of scrotal pain or swelling in children and adolescents\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?42/47/43766?source=see_link\">",
"     \"Causes of painless scrotal swelling in children and adolescents\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     TESTICULAR TORSION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Testicular torsion is the most dramatic and potentially serious of the acute processes affecting the scrotal contents because it may result in the loss of the testicle. Normal testicular anatomy is depicted in the figure (",
"    <a class=\"graphic graphic_figure graphicRef75672 \" href=\"mobipreview.htm?32/1/32786\">",
"     figure 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Intravaginal torsion results from inadequate fixation of the testis to the tunica vaginalis through the gubernaculum testis. The most common abnormality associated with testicular torsion is known as the \"bell clapper\" deformity: the testicle lacks the normal attachment to the tunica vaginalis (permitting increased mobility) and rests transverse within the scrotum (",
"    <a class=\"graphic graphic_figure graphicRef55518 \" href=\"mobipreview.htm?38/36/39491\">",
"     figure 2",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32376/abstract/2\">",
"     2",
"    </a>",
"    ]. The bell clapper deformity may be bilateral and predisposes to testicular torsion.",
"   </p>",
"   <p>",
"    If fixation of the lower pole of the testis to the tunica vaginalis is insufficiently broad-based or absent, the testis may torse (twist) on the spermatic cord (",
"    <a class=\"graphic graphic_figure graphicRef77468 \" href=\"mobipreview.htm?1/28/1475\">",
"     figure 3",
"    </a>",
"    ). The twisting of the spermatic cord within the tunica vaginalis causes venous compression and subsequent edema of the testicle and cord with ultimate ischemia of the testicle caused by arterial occlusion [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32376/abstract/2,3\">",
"     2,3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Neonatal testicular torsion, which is extravaginal, is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?0/44/712?source=see_link\">",
"     \"Neonatal testicular torsion\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Testicular torsion has two peak incidences: a small one in the neonatal period and a large one during puberty, but it can occur at any age. The incidence is estimated to be 1 in 4000 in males younger than 25 years old [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32376/abstract/4\">",
"     4",
"    </a>",
"    ]. Approximately 65 percent of cases occur in boys between the ages of 12 and 18 years [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32376/abstract/5,6\">",
"     5,6",
"    </a>",
"    ]. The increased incidence during adolescence is thought to be secondary to the increasing weight of the testes during pubertal development [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32376/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Clinical presentation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients classically present with an abrupt onset of severe testicular or scrotal pain, usually of less than 12 hours' duration [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32376/abstract/2,8,9\">",
"     2,8,9",
"    </a>",
"    ]; however, inguinal or lower abdominal pain may be the presenting complaint [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32376/abstract/10\">",
"     10",
"    </a>",
"    ]. Nearly 90 percent of patients may have associated nausea and vomiting [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32376/abstract/11,12\">",
"     11,12",
"    </a>",
"    ]. The pain can be isolated to the scrotum or may radiate to the lower abdomen [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32376/abstract/5,7\">",
"     5,7",
"    </a>",
"    ]. The pain is constant unless the testicle is torsing and detorsing. A typical presentation, particularly in children, is for the patient to awaken with scrotal pain in the middle of the night or in the morning. Many boys report a previous episode of pain [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32376/abstract/2,5,7,13\">",
"     2,5,7,13",
"    </a>",
"    ]. However, one study reported only 8 percent of the patients with torsion had a history of pain in the past [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32376/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    On physical examination, the scrotum may be edematous, indurated and erythematous and the affected testis usually is tender, swollen, and slightly elevated because of shortening of the cord from twisting. The testis may be lying horizontally, displacing the epididymis from its normal posterolateral position. A reactive hydrocele may also be present.",
"   </p>",
"   <p>",
"    The cremasteric reflex (elevation of the testis in response to stroking of the upper inner thigh) is absent in nearly all cases of torsion, but it also may be absent in boys without torsion, particularly if they are younger than six months [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32376/abstract/8,9,14-17\">",
"     8,9,14-17",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Prehn reported that elevation of the scrotal contents relieves the pain in patients with epididymitis and aggravates or has no effect on the pain in patients with testicular torsion [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32376/abstract/5\">",
"     5",
"    </a>",
"    ]. However, Prehn sign is not a reliable distinguishing feature between torsion and other diagnoses [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32376/abstract/5,13,18\">",
"     5,13,18",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h3\">",
"     Intermittent torsion",
"    </span>",
"    &nbsp;&mdash;&nbsp;Intermittent testicular torsion, characterized by acute and intermittent sharp testicular pain and scrotal swelling, with rapid resolution (within seconds to a few minutes) and long intervals without symptoms, should be considered in all boys with a history of such scrotal pain and swelling without other identifiable causes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32376/abstract/19,20\">",
"     19,20",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In one review of 50 patients with intermittent testicular torsion, 26 percent reported nausea or vomiting, and 21 percent reported that the pain awakened them from sleep [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32376/abstract/20\">",
"     20",
"    </a>",
"    ]. Physical findings of intermittent testicular torsion may include horizontal or very mobile testes, anterior epididymis, or bulkiness of the spermatic cord from partial twisting [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32376/abstract/19,20\">",
"     19,20",
"    </a>",
"    ]. These findings are usually present to varying degrees on physical examination. However, the clinical and radiographic evaluations of some boys with intermittent torsion may be normal, highlighting the importance of immediate follow-up for recurrent or worsening pain.",
"   </p>",
"   <p>",
"    Boys with intermittent complaints and normal evaluation at the time of presentation should have a follow-up evaluation within seven days unless pain recurs sooner. Unfortunately, intermittent testicular torsion most often leaves no clinical trace, but on those occasions when intermittent testicular torsion is suspected, consultation with or referral to urology is recommended.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of testicular torsion can be made clinically, as described above. One study found that the absence of ipsilateral cremasteric reflex, skin changes and the presence of nausea and or vomiting are most consistently predictive of torsion [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32376/abstract/21\">",
"     21",
"    </a>",
"    ]. Radiologic evaluation (a color Doppler ultrasound or nuclear scan of the scrotum) should be undertaken if the certainty of the diagnosis is in question and the performance of imaging studies will not significantly delay treatment. Demonstration of decreased testicular perfusion with either of these scans is consistent with testicular torsion. Decreased testicular perfusion also can be seen in some patients with a large hydrocele, abscess, hematoma, or scrotal hernia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32376/abstract/12\">",
"     12",
"    </a>",
"    ]. Negative scans (ie, normal or increased testicular flow) may occur rarely [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32376/abstract/9,19\">",
"     9,19",
"    </a>",
"    ], usually with spontaneous detorsion and partial or intermittent torsion [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32376/abstract/19\">",
"     19",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The Doppler ultrasound can discern testicular and epididymal size, scrotal fluid, scrotal wall thickening, enlarged appendix testis, and arterial flow in the testis and epididymis. The reported sensitivity and specificity of Doppler ultrasound in the detection of testicular torsion range from 69 to 100 percent and 77 to 100 percent, respectively [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32376/abstract/8,22-27\">",
"     8,22-27",
"    </a>",
"    ]. The usefulness of Doppler ultrasound is limited in small prepubertal testes with lower blood flow.",
"   </p>",
"   <p>",
"    The nuclear scan measures testicular perfusion. The reported sensitivity and specificity of scintigraphy are 100 percent and 97 percent, respectively [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32376/abstract/23,27\">",
"     23,27",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Management",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of testicular torsion, whether clinically or radiographically made, requires immediate consultation with an urologist (",
"    <a class=\"graphic graphic_table graphicRef64809 \" href=\"mobipreview.htm?24/56/25485\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    The treatment for a torsed testicle that remains viable involves surgical detorsion and fixation (orchiopexy) of both testes. Orchiectomy is performed if the testicle is nonviable. The viability of a torsed testicle is dependent upon the duration and completeness of torsion. Typical rates of viability according to duration of torsion have been described as follows [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32376/abstract/5,7,13\">",
"     5,7,13",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Detorsion within 4 to 6 hours &mdash; 100 percent viability",
"     </li>",
"     <li>",
"      Detorsion after 12 hours &mdash; 20 percent viability",
"     </li>",
"     <li>",
"      Detorsion after 24 hours &mdash; 0 percent viability",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Surgery never should be delayed on the assumption of nonviability based on a clinical estimate of duration of torsion. Some patients with a prolonged period of symptoms may have had intermittent torsion or a partial torsion and testicles that are salvageable.",
"   </p>",
"   <p>",
"    The contralateral hemiscrotum typically is explored during surgery because the bell clapper deformity usually is bilateral. Exploration permits fixation of the contralateral testis to prevent future torsion [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32376/abstract/2,5,13,28\">",
"     2,5,13,28",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Some authors report decreased fertility after unilateral testicular torsion when the testis is left in situ [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32376/abstract/29-32\">",
"     29-32",
"    </a>",
"    ], possibly because of immune-mediated damage to the contralateral testis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32376/abstract/31,33,34\">",
"     31,33,34",
"    </a>",
"    ]. However, no evidence of decreased fertility or anti-sperm antibodies was found in one study of prepubertal boys with testicular torsion [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32376/abstract/35\">",
"     35",
"    </a>",
"    ], and the fertility issue remains controversial.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Manual detorsion",
"    </span>",
"    &nbsp;&mdash;&nbsp;Manual detorsion of the torsed testicle may be considered if the child presents before scrotal swelling develops [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32376/abstract/12,36,37\">",
"     12,36,37",
"    </a>",
"    ]. Unless there are extenuating circumstances (ie, definitive care is hours away), the procedure should typically be performed by clinicians experienced in the technique, and only after appropriate sedation and analgesia have been administered [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32376/abstract/12\">",
"     12",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?42/23/43384?source=see_link\">",
"     \"Procedural sedation in children outside of the operating room\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The classic teaching is that the testis usually rotates medially and is detorsed by rotating it outward toward the thigh. However, in a retrospective analysis of 200 consecutive boys aged 18 months to 20 years who underwent surgical exploration for testicular torsion, lateral rotation was present in one-third of cases [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32376/abstract/38\">",
"     38",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Successful detorsion is suggested by relief of pain, lower position of the testis in the scrotum, and return of normal arterial pulsations detected with a Doppler stethoscope [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32376/abstract/12\">",
"     12",
"    </a>",
"    ]. Surgical exploration is necessary even after clinically successful manual detorsion because orchiopexy must be performed to prevent an additional episode [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32376/abstract/38\">",
"     38",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Neonatal testicular torsion",
"    </span>",
"    &nbsp;&mdash;&nbsp;Neonatal testicular torsion is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?0/44/712?source=see_link\">",
"     \"Neonatal testicular torsion\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     TORSION OF THE APPENDIX TESTIS OR APPENDIX EPIDIDYMIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The appendix testis is a small vestigial structure on the anterosuperior aspect of the testis (an embryologic remnant of the M&uuml;llerian duct system) (",
"    <a class=\"graphic graphic_figure graphicRef67439 \" href=\"mobipreview.htm?8/60/9152\">",
"     figure 4",
"    </a>",
"    ). It measures about 0.3 cm. The appendix epididymis is a vestigial remnant of the Wolffian duct that is located at the head of the epididymis. The pedunculated shape of these appendages predisposes them to torsion, which can produce scrotal pain that ranges from mild to severe. Torsion of the appendix testis or appendix epididymis (",
"    <a class=\"graphic graphic_figure graphicRef67439 \" href=\"mobipreview.htm?8/60/9152\">",
"     figure 4",
"    </a>",
"    ) occurs most commonly in boys between 7 and 12 years of age [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32376/abstract/39\">",
"     39",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Clinical presentation",
"    </span>",
"    &nbsp;&mdash;&nbsp;The pain of torsion of the appendix testis or appendix epididymis is of sudden onset, like the pain of testicular torsion.",
"   </p>",
"   <p>",
"    Physical examination of boys with torsion of the appendix testis or epididymis typically demonstrates a nontender testicle and a tender localized mass that is palpable, usually at the superior or inferior pole. The appendix may be gangrenous or black and appears through the scrotum as the \"blue dot sign\" (",
"    <a class=\"graphic graphic_picture graphicRef65781 \" href=\"mobipreview.htm?38/25/39327\">",
"     picture 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    A normal cremasteric reflex may be present, and a reactive hydrocele may be palpated. Blood flow to the affected testis is normal or increased and can be demonstrated on Doppler ultrasound or nuclear scan [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32376/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of torsion of the appendix testis or appendix epididymis can be made clinically, as described above. Doppler ultrasound or nuclear scan may be helpful in cases where testicular torsion cannot otherwise be excluded.",
"   </p>",
"   <p>",
"    Testicular ultrasound will show the torsed appendage as a lesion of low echogenicity with a central hypoechogenic area [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32376/abstract/40\">",
"     40",
"    </a>",
"    ]. Color Doppler reveals normal blood flow to the testis with an occasional increase on the affected side, possibly due to inflammation. Doppler may be less accurate in a prepubertal patient because of lower baseline testicular perfusion.",
"   </p>",
"   <p>",
"    Radionuclide imaging denotes a \"hot dot\" sign at the torsed appendage. However, this finding is unreliable if the symptoms are less than five hours old and will be seen in only 45 percent of patients whose symptoms have lasted 5 to 24 hours [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32376/abstract/41\">",
"     41",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Management",
"    </span>",
"    &nbsp;&mdash;&nbsp;The management of a torsed appendix testis or appendix epididymis is supportive, with analgesics, bed rest, and scrotal support to help alleviate swelling (",
"    <a class=\"graphic graphic_table graphicRef64809 \" href=\"mobipreview.htm?24/56/25485\">",
"     table 1",
"    </a>",
"    ). The pain should resolve in 5 to 10 days. Surgery (removal of the testicular appendix) is reserved for patients who have persistent pain; the contralateral hemiscrotum need not be explored [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32376/abstract/5,13,42\">",
"     5,13,42",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     EPIDIDYMITIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Inflammation of the epididymis is known as epididymitis (",
"    <a class=\"graphic graphic_figure graphicRef73122 \" href=\"mobipreview.htm?28/50/29477\">",
"     figure 5",
"    </a>",
"    ). Epididymitis occurs more frequently among late adolescents, but also occurs in younger boys who deny sexual activity [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32376/abstract/7,8,13\">",
"     7,8,13",
"    </a>",
"    ]. Several factors may predispose postpubertal boys to develop subacute epididymitis, including sexual activity, heavy physical exertion, and direct trauma (eg, bicycle or motorcycle riding). Bacterial epididymitis in prepubertal boys is associated with structural anomalies of the urinary tract [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32376/abstract/43-45\">",
"     43-45",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Among sexually active males, chlamydia is the most common microbial agent, followed by N. gonorrhea, E. coli, and viruses. Organisms that less commonly cause epididymitis include Ureaplasma, Mycobacterium, and cytomegalovirus, or cryptococcus in patients with HIV infection.",
"   </p>",
"   <p>",
"    Infectious epididymitis in prepubertal boys and adolescents who are not sexually active may be caused by Mycoplasma pneumoniae, enteroviruses, or adenoviruses [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32376/abstract/46\">",
"     46",
"    </a>",
"    ]. Bacterial infection appears to be uncommon in such patients. As an example, an observational study of 97 cases of epididymitis who had urine cultures found that only 4 percent had a bacterial infection and, in patients with positive urine cultures, the organisms isolated frequently were not sensitive to commonly prescribed empiric antibiotics [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32376/abstract/47\">",
"     47",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Clinical presentation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with epididymitis may present with acute or subacute onset of pain and swelling isolated to the epididymis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32376/abstract/45\">",
"     45",
"    </a>",
"    ]. A history of frequency, dysuria, urethral discharge,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    fever may be present [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32376/abstract/2,8,12\">",
"     2,8,12",
"    </a>",
"    ]. On physical examination, the affected testis has a normal vertical lie; the scrotum may be red and parchment-like (although this is an uncommon finding); scrotal edema is present in at least 50 percent of cases [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32376/abstract/8,10,11\">",
"     8,10,11",
"    </a>",
"    ]. Sometimes an inflammatory nodule is felt with an otherwise soft, nontender epididymis.",
"   </p>",
"   <p>",
"    In contrast to patients with testicular torsion, patients with epididymitis usually have a normal cremasteric reflex (if they have a one under normal conditions) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32376/abstract/2,8\">",
"     2,8",
"    </a>",
"    ]. Patients with epididymitis may experience pain relief with elevation of the testis (Prehn sign), but this is not a reliable marker for epididymitis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32376/abstract/5,13,18\">",
"     5,13,18",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Patients with epididymitis may have leukocytosis and pyuria; however, urinalysis may be normal. Urine culture often is negative. In one retrospective study of patients with acute scrotal pathology, only 15 percent of those with epididymitis had a positive urinalysis (&gt;10 white blood cells per high-power field) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32376/abstract/8\">",
"     8",
"    </a>",
"    ]. Earlier studies reported positive urinalysis in 24 to 59 percent of patients with epididymitis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32376/abstract/44,48\">",
"     44,48",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of epididymitis can be made clinically as described above. However, if the diagnosis is uncertain, Doppler ultrasonography or nuclear scan may be helpful, revealing increased blood flow to the affected epididymis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32376/abstract/40,49\">",
"     40,49",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A urinalysis and urine culture should be obtained in all patients with epididymitis. In addition, the Centers for Disease Control (CDC) recommend that providers obtain the following studies in patients who have findings consistent with sexually transmitted epididymitis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32376/abstract/50\">",
"     50",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Gram-stained smear and culture of urethral exudates or intraurethral swab specimen,",
"      <strong>",
"       or",
"      </strong>",
"     </li>",
"     <li>",
"      Nucleic acid amplification tests for N. gonorrhea and C. trachomatis,",
"      <strong>",
"       and",
"      </strong>",
"     </li>",
"     <li>",
"      Urine culture and first void urine for leukocytes",
"     </li>",
"     <li>",
"      Syphilis and HIV testing",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Management",
"    </span>",
"    &nbsp;&mdash;&nbsp;Treatment varies according to the severity of the case at presentation and suspected etiology (",
"    <a class=\"graphic graphic_table graphicRef64809 \" href=\"mobipreview.htm?24/56/25485\">",
"     table 1",
"    </a>",
"    ). Treatment for sexually transmitted epididymitis includes antibiotics [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32376/abstract/50\">",
"     50",
"    </a>",
"    ], analgesics, scrotal support, elevation, and bed rest in the acute phase [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32376/abstract/50\">",
"     50",
"    </a>",
"    ]. It is equally important to assure that the sexual partner gets treatment if a sexually transmitted disease is suspected as the etiology. The diagnosis and treatment regimen should be reevaluated if there is no improvement after three days of therapy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32376/abstract/50\">",
"     50",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The first-line treatment regimen recommended by the CDC when the most likely cause is chlamydia or gonorrhea includes",
"      <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?0/19/312?source=see_link\">",
"       ceftriaxone",
"      </a>",
"      (250 mg IM in one dose)",
"      <strong>",
"       plus",
"      </strong>",
"      &nbsp;",
"      <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?11/54/12136?source=see_link\">",
"       doxycycline",
"      </a>",
"      (100 mg PO twice a day for 10 days) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/39/32376/abstract/50,51\">",
"       50,51",
"      </a>",
"      ]. Quinolones are no longer recommended for the treatment of epididymitis if N. gonorrhoeae is suspected because of increasing resistance of N. gonorrhoeae to these agents.",
"     </li>",
"     <li>",
"      For acute epididymitis most likely caused by enteric organisms or with negative gonococcal culture or nucleic acid amplification test,",
"      <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?36/35/37424?source=see_link\">",
"       ofloxacin",
"      </a>",
"      (300 mg PO twice a day for 10 days) or",
"      <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?33/11/33968?source=see_link\">",
"       levofloxacin",
"      </a>",
"      (500 mg PO once daily for 10 days) may be used [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/39/32376/abstract/51\">",
"       51",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    It should be noted that",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?11/54/12136?source=see_link\">",
"     doxycycline",
"    </a>",
"    is not approved for use in children younger than the age of eight years and that fluoroquinolones are not approved for use in patients younger than 18 years of age when other effective alternatives are available [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32376/abstract/52\">",
"     52",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The treatment of epididymitis in prepubertal boys depends upon whether they have an associated urinary tract infection. Those who have pyuria, positive urine cultures, or underlying risk factors for urinary tract infection should be treated empirically with antibiotics that cover coliforms and achieve adequate levels in epididymal tissues (eg,",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?40/23/41336?source=see_link\">",
"     trimethoprim-sulfamethoxazole",
"    </a>",
"    ,",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?30/5/30804?source=see_link\">",
"     cephalexin",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32376/abstract/12\">",
"     12",
"    </a>",
"    ]. Additional evaluation of boys with urinary tract infection is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?27/1/27674?source=see_link&amp;anchor=H15#H15\">",
"     \"Acute management, imaging, and prognosis of urinary tract infections in infants and children older than one month\", section on 'Imaging'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The treatment of nonbacterial epididymitis is supportive and includes scrotal support, rest, NSAIDs, and possibly antibiotics [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32376/abstract/53\">",
"     53",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h1\">",
"     OTHER CAUSES",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Trauma",
"    </span>",
"    &nbsp;&mdash;&nbsp;It is not uncommon for boys and men to suffer minor episodes of scrotal trauma; only rarely does a severe testicular injury result, usually because of compression of the testis against the pubic bones from a direct blow or straddle injury. The spectrum of injuries can range from a hematocele (hematoma in the tunica vaginalis) to an intratesticular hematoma to disruption of the tunica albuginea causing testicular rupture. Color Doppler ultrasonography can accurately diagnose the extent of injury. Testicular rupture requires surgical repair. Lesser injuries are managed according to the clinical severity and often can be treated nonoperatively.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Incarcerated inguinal hernia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Herniation of bowel or omentum into the scrotum can present with pain and a scrotal mass (",
"    <a class=\"graphic graphic_picture graphicRef76424 \" href=\"mobipreview.htm?35/41/36496\">",
"     picture 2",
"    </a>",
"    ). Bowel sounds may be audible in the scrotum. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?21/3/21561?source=see_link\">",
"     \"Overview of inguinal hernia in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Henoch-Sch&ouml;nlein purpura (IgA vasculitis)",
"    </span>",
"    &nbsp;&mdash;&nbsp;Henoch-Sch&ouml;nlein purpura (HSP [IgA vasculitis (IgAV)]) is a systemic vasculitis syndrome characterized by nonthrombocytopenic purpura, arthralgia, renal disease, abdominal pain, gastrointestinal bleeding, and occasionally scrotal pain. In one review of 93 boys with HSP (IgAV), 22 had scrotal involvement [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32376/abstract/54\">",
"     54",
"    </a>",
"    ]. The onset of scrotal pain may be acute or insidious. In boys who lack other characteristic findings of HSP (IgAV), sonography can usually distinguish HSP (IgAV) from testicular torsion. Treatment of HSP (IgAV) is supportive. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?27/62/28646?source=see_link\">",
"     \"Management of Henoch-Sch&ouml;nlein purpura (IgA vasculitis)\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Orchitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Viral (mumps, rubella, coxsackie, echovirus, lymphocytic choriomeningitis virus, parvovirus) and bacterial (brucellosis) infections can cause orchitis in children and adolescents [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32376/abstract/55\">",
"     55",
"    </a>",
"    ]. Clinical manifestations may include scrotal swelling, pain, and tenderness with erythema and shininess of the overlying skin, although the presentation may be more severe. (See appropriate topic reviews).",
"   </p>",
"   <p>",
"    Patients with orchitis are treated symptomatically with bed rest, nonsteroidal antiinflammatory agents, support of the inflamed testis, and ice packs. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?7/61/8154?source=see_link&amp;anchor=H30#H30\">",
"     \"Epidemiology, clinical manifestations, diagnosis and management of mumps\", section on 'Treatment'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Referred pain",
"    </span>",
"    &nbsp;&mdash;&nbsp;Boys who have the acute onset of scrotal pain without local inflammatory signs or a mass on examination may be suffering from referred pain to the scrotum. The precise incidence of referred pain is unclear. The conditions that may cause referred scrotal pain are diverse, reflecting the anatomy of the three somatic nerves that travel to the scrotum: the genitofemoral, ilioinguinal, and posterior scrotal nerves [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32376/abstract/56\">",
"     56",
"    </a>",
"    ]. Retrocecal appendicitis is an important (albeit uncommon) cause of referred scrotal pain in children and adolescents [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32376/abstract/57\">",
"     57",
"    </a>",
"    ]. Reported causes of referred pain in adults include abdominal aortic aneurysm, urolithiasis, lower lumbar or sacral nerve root impingement, retrocecal appendicitis, retroperitoneal tumor, and postherniorrhaphy pain [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32376/abstract/56\">",
"     56",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?32/3/32826?source=see_link\">",
"     \"Acute appendicitis in children: Clinical manifestations and diagnosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h2\">",
"     Nonspecific scrotal pain",
"    </span>",
"    &nbsp;&mdash;&nbsp;Sometimes older boys and young teenagers present with complaints of",
"    <strong>",
"     mild",
"    </strong>",
"    scrotal pain and a completely normal physical examination. These characteristics make testicular torsion and other pathologic conditions highly unlikely. Imaging of such patients is not usually necessary. They should be instructed to return for immediate evaluation if the pain increases in severity or is associated with testicular swelling.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topic (see",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?18/30/18914?source=see_link\">",
"       \"Patient information: Epididymitis (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The clinical presentations, diagnosis, and management of the most common causes of testicular or scrotal pain in children and adolescents are described above (",
"    <a class=\"graphic graphic_table graphicRef54439 \" href=\"mobipreview.htm?18/31/18941\">",
"     table 2",
"    </a>",
"    and",
"    <a class=\"graphic graphic_table graphicRef64809 \" href=\"mobipreview.htm?24/56/25485\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The differential diagnosis of acute scrotal pain primarily includes testicular torsion, torsion of the appendix testis, and epididymitis.",
"     </li>",
"     <li>",
"      Testicular torsion generally presents with the abrupt onset of severe pain. The testicle may lie transversely in the scrotum and be retracted; the cremasteric reflex is typically absent. Testicular torsion is an emergency; timely diagnosis and treatment are vital for survival of the testis. At the time of diagnosis it is reasonable to attempt manual detorsion. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Manual detorsion'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Torsion of the appendix testis also presents with the abrupt onset of pain, but the pain typically is less severe than in testicular torsion. Pain is localized to the region of the appendix testis (anterosuperior), and a \"blue dot\" sign may be apparent at the same location (",
"      <a class=\"graphic graphic_picture graphicRef65781 \" href=\"mobipreview.htm?38/25/39327\">",
"       picture 1",
"      </a>",
"      ). Treatment may be symptomatic, or the appendix testis may be surgically excised. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Torsion of the appendix testis or appendix epididymis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Patients with epididymitis may present with acute or subacute onset of pain and swelling isolated to the epididymis. A history of frequency, dysuria, urethral discharge,",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      fever may be present. The affected testis has a normal vertical lie; scrotal edema often is present. Treatment depends on the severity of illness and the suspected etiology. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Epididymitis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In rare cases, retrocecal appendicitis may cause referred scrotal pain in children and adolescents. In these patients, primary scrotal or testicular pathology will be absent.",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32376/abstract/1\">",
"      Lewis AG, Bukowski TP, Jarvis PD, et al. Evaluation of acute scrotum in the emergency department. J Pediatr Surg 1995; 30:277.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32376/abstract/2\">",
"      Kass EJ, Lundak B. The acute scrotum. Pediatr Clin North Am 1997; 44:1251.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32376/abstract/3\">",
"      Tumeh SS, Benson CB, Richie JP. Acute diseases of the scrotum. Semin Ultrasound CT MR 1991; 12:115.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32376/abstract/4\">",
"      Williamson RC. Torsion of the testis and allied conditions. Br J Surg 1976; 63:465.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32376/abstract/5\">",
"      Edelsberg JS, Surh YS. The acute scrotum. Emerg Med Clin North Am 1988; 6:521.",
"     </a>",
"    </li>",
"    <li>",
"     Rohn RD. Male genitalia: Examination and findings. In: Comprehensive Adolescent Health Care,, Friedman SB, Fisher M, Schonberg SK, et al.  (Eds), Mosby-Year Book, St. Louis 1998. p.1078.",
"    </li>",
"    <li>",
"     Anderson MM, Neinstein LS. Scrotal disorders. In: Adolescent Health Care: A Practical Guide, Neinstein LS.  (Ed), Williams &amp; Wilkins, Baltimore 1996. p.464.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32376/abstract/8\">",
"      Kadish HA, Bolte RG. A retrospective review of pediatric patients with epididymitis, testicular torsion, and torsion of testicular appendages. Pediatrics 1998; 102:73.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32376/abstract/9\">",
"      Karmazyn B, Steinberg R, Kornreich L, et al. Clinical and sonographic criteria of acute scrotum in children: a retrospective study of 172 boys. Pediatr Radiol 2005; 35:302.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32376/abstract/10\">",
"      Petrack EM, Hafeez W. Testicular torsion versus epididymitis: a diagnostic challenge. Pediatr Emerg Care 1992; 8:347.",
"     </a>",
"    </li>",
"    <li>",
"     Tunnessen WW Jr. Scrotal swelling. In: Signs and Symptoms in Pediatrics, 3rd, Lippincott, Williams &amp; Wilkins, Philadelphia 1999. p.606.",
"    </li>",
"    <li>",
"     Perron CE. Pain: Scrotal. In: Textbook of Pediatric Emergency Medicine, 5th, Fleisher GR, Ludwig S, Henretig FM.  (Eds), Lippincott Williams &amp; Wilkins, Philadelphia 2006. p.525.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32376/abstract/13\">",
"      Pillai SB, Besner GE. Pediatric testicular problems. Pediatr Clin North Am 1998; 45:813.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32376/abstract/14\">",
"      Caldamone AA, Valvo JR, Altebarmakian VK, Rabinowitz R. Acute scrotal swelling in children. J Pediatr Surg 1984; 19:581.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32376/abstract/15\">",
"      Rabinowitz R. The importance of the cremasteric reflex in acute scrotal swelling in children. J Urol 1984; 132:89.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32376/abstract/16\">",
"      Nelson CP, Williams JF, Bloom DA. The cremasteric reflex: a useful but imperfect sign in testicular torsion. J Pediatr Surg 2003; 38:1248.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32376/abstract/17\">",
"      Caesar RE, Kaplan GW. The incidence of the cremasteric reflex in normal boys. J Urol 1994; 152:779.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32376/abstract/18\">",
"      Haynes BE, Bessen HA, Haynes VE. The diagnosis of testicular torsion. JAMA 1983; 249:2522.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32376/abstract/19\">",
"      Stillwell TJ, Kramer SA. Intermittent testicular torsion. Pediatrics 1986; 77:908.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32376/abstract/20\">",
"      Eaton SH, Cendron MA, Estrada CR, et al. Intermittent testicular torsion: diagnostic features and management outcomes. J Urol 2005; 174:1532.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32376/abstract/21\">",
"      Srinivasan A, Cinman N, Feber KM, et al. History and physical examination findings predictive of testicular torsion: an attempt to promote clinical diagnosis by house staff. J Pediatr Urol 2011; 7:470.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32376/abstract/22\">",
"      Lam WW, Yap TL, Jacobsen AS, Teo HJ. Colour Doppler ultrasonography replacing surgical exploration for acute scrotum: myth or reality? Pediatr Radiol 2005; 35:597.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32376/abstract/23\">",
"      Paltiel HJ, Connolly LP, Atala A, et al. Acute scrotal symptoms in boys with an indeterminate clinical presentation: comparison of color Doppler sonography and scintigraphy. Radiology 1998; 207:223.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32376/abstract/24\">",
"      Baker LA, Sigman D, Mathews RI, et al. An analysis of clinical outcomes using color doppler testicular ultrasound for testicular torsion. Pediatrics 2000; 105:604.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32376/abstract/25\">",
"      Yazbeck S, Patriquin HB. Accuracy of Doppler sonography in the evaluation of acute conditions of the scrotum in children. J Pediatr Surg 1994; 29:1270.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32376/abstract/26\">",
"      Kass EJ, Stone KT, Cacciarelli AA, Mitchell B. Do all children with an acute scrotum require exploration? J Urol 1993; 150:667.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32376/abstract/27\">",
"      Nussbaum Blask AR, Bulas D, Shalaby-Rana E, et al. Color Doppler sonography and scintigraphy of the testis: a prospective, comparative analysis in children with acute scrotal pain. Pediatr Emerg Care 2002; 18:67.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32376/abstract/28\">",
"      Sheldon CA. Undescended testis and testicular torsion. Surg Clin North Am 1985; 65:1303.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32376/abstract/29\">",
"      Bartsch G, Frank S, Marberger H, Mikuz G. Testicular torsion: late results with special regard to fertility and endocrine function. J Urol 1980; 124:375.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32376/abstract/30\">",
"      Krarup T. The testes after torsion. Br J Urol 1978; 50:43.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32376/abstract/31\">",
"      Mastrogiacomo I, Zanchetta R, Graziotti P, et al. Immunological and clinical study of patients after spermatic cord torsion. Andrologia 1982; 14:25.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32376/abstract/32\">",
"      Williamson RC, Thomas WE. Sympathetic orchidopathia. Ann R Coll Surg Engl 1984; 66:264.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32376/abstract/33\">",
"      Harrison RG, Lewis-Jones DI, Moreno de Marval MJ, Connolly RC. Mechanism of damage to the contralateral testis in rats with an ischaemic testis. Lancet 1981; 2:723.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32376/abstract/34\">",
"      Zanchetta R, Mastrogiacomo I, Graziotti P, et al. Autoantibodies against Leydig cells in patients after spermatic cord torsion. Clin Exp Immunol 1984; 55:49.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32376/abstract/35\">",
"      Puri P, Barton D, O'Donnell B. Prepubertal testicular torsion: subsequent fertility. J Pediatr Surg 1985; 20:598.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32376/abstract/36\">",
"      Garel L, Dubois J, Azzie G, et al. Preoperative manual detorsion of the spermatic cord with Doppler ultrasound monitoring in patients with intravaginal acute testicular torsion. Pediatr Radiol 2000; 30:41.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32376/abstract/37\">",
"      Cornel EB, Karthaus HF. Manual derotation of the twisted spermatic cord. BJU Int 1999; 83:672.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32376/abstract/38\">",
"      Sessions AE, Rabinowitz R, Hulbert WC, et al. Testicular torsion: direction, degree, duration and disinformation. J Urol 2003; 169:663.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32376/abstract/39\">",
"      Fisher R, Walker J. The acute paediatric scrotum. Br J Hosp Med 1994; 51:290.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32376/abstract/40\">",
"      Baldisserotto M. Scrotal emergencies. Pediatr Radiol 2009; 39:516.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32376/abstract/41\">",
"      Melloul M, Paz A, Lask D, et al. The pattern of radionuclide scrotal scan in torsion of testicular appendages. Eur J Nucl Med 1996; 23:967.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32376/abstract/42\">",
"      Flanigan RC, DeKernion JB, Persky L. Acute scrotal pain and swelling in children: a surgical emergency. Urology 1981; 17:51.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32376/abstract/43\">",
"      Merlini E, Rotundi F, Seymandi PL, Canning DA. Acute epididymitis and urinary tract anomalies in children. Scand J Urol Nephrol 1998; 32:273.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32376/abstract/44\">",
"      Siegel A, Snyder H, Duckett JW. Epididymitis in infants and boys: underlying urogenital anomalies and efficacy of imaging modalities. J Urol 1987; 138:1100.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32376/abstract/45\">",
"      Likitnukul S, McCracken GH Jr, Nelson JD, Votteler TP. Epididymitis in children and adolescents. A 20-year retrospective study. Am J Dis Child 1987; 141:41.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32376/abstract/46\">",
"      Somekh E, Gorenstein A, Serour F. Acute epididymitis in boys: evidence of a post-infectious etiology. J Urol 2004; 171:391.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32376/abstract/47\">",
"      Santillanes G, Gausche-Hill M, Lewis RJ. Are antibiotics necessary for pediatric epididymitis? Pediatr Emerg Care 2011; 27:174.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32376/abstract/48\">",
"      Gislason T, Noronha RF, Gregory JG. Acute epididymitis in boys: a 5-year retrospective study. J Urol 1980; 124:533.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32376/abstract/49\">",
"      Schalamon J, Ainoedhofer H, Schleef J, et al. Management of acute scrotum in children--the impact of Doppler ultrasound. J Pediatr Surg 2006; 41:1377.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32376/abstract/50\">",
"      Centers for Disease Control and Prevention, Workowski KA, Berman SM. Sexually transmitted diseases treatment guidelines, 2006. MMWR Recomm Rep 2006; 55:1.",
"     </a>",
"    </li>",
"    <li>",
"     Updated recommended treatment regimens for gonococcal infections and associated conditions -- United States, April 2007. www.cdc.gov/std/treatment/2006/GonUpdateApril2007.pdf (Accessed on April 18, 2007).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32376/abstract/52\">",
"      Committee on Infectious Diseases. The use of systemic fluoroquinolones. Pediatrics 2006; 118:1287.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32376/abstract/53\">",
"      Lau P, Anderson PA, Giacomantonio JM, Schwarz RD. Acute epididymitis in boys: are antibiotics indicated? Br J Urol 1997; 79:797.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32376/abstract/54\">",
"      Ioannides AS, Turnock R. An audit of the management of the acute scrotum in children with Henoch-Schonlein Purpura. J R Coll Surg Edinb 2001; 46:98.",
"     </a>",
"    </li>",
"    <li>",
"     Green MG. The genitalia. In: Pediatric Diagnosis: Interpretatino of Symptoms and Signs in Children and Adolescents, 6th, WB Saunders, Philadelphia 1998. p.101.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32376/abstract/56\">",
"      McGee SR. Referred scrotal pain: case reports and review. J Gen Intern Med 1993; 8:694.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32376/abstract/57\">",
"      M&eacute;ndez R, Tellado M, Montero M, et al. Acute scrotum: an exceptional presentation of acute nonperforated appendicitis in childhood. J Pediatr Surg 1998; 33:1435.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 6446 Version 6.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1105-213.131.41.98-E13A3EE944-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f31_39_32376=[""].join("\n");
var outline_f31_39_32376=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H24\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      TESTICULAR TORSION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Clinical presentation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      - Intermittent torsion",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Diagnosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Management",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Manual detorsion",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Neonatal testicular torsion",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      TORSION OF THE APPENDIX TESTIS OR APPENDIX EPIDIDYMIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Clinical presentation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Diagnosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Management",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      EPIDIDYMITIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Clinical presentation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Diagnosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Management",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      OTHER CAUSES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Trauma",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Incarcerated inguinal hernia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Henoch-Sch&ouml;nlein purpura (IgA vasculitis)",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Orchitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Referred pain",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      Nonspecific scrotal pain",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"EM/6446\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/6446|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?32/1/32786\" title=\"figure 1\">",
"      Scrotal anatomy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?38/36/39491\" title=\"figure 2\">",
"      Bell clapper deformity",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?1/28/1475\" title=\"figure 3\">",
"      Torsion of spermatic cord",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?8/60/9152\" title=\"figure 4\">",
"      Testicular appendages",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?28/50/29477\" title=\"figure 5\">",
"      Etiology of epididymitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/6446|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?38/25/39327\" title=\"picture 1\">",
"      Appendix testis torsion",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?35/41/36496\" title=\"picture 2\">",
"      Strangulated hernia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/6446|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?24/56/25485\" title=\"table 1\">",
"      Acute scrotum disposition",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?18/31/18941\" title=\"table 2\">",
"      Differential diagnosis of pediatric scrotal pain",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?32/3/32826?source=related_link\">",
"      Acute appendicitis in children: Clinical manifestations and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?27/1/27674?source=related_link\">",
"      Acute management, imaging, and prognosis of urinary tract infections in infants and children older than one month",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?42/47/43766?source=related_link\">",
"      Causes of painless scrotal swelling in children and adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?7/61/8154?source=related_link\">",
"      Epidemiology, clinical manifestations, diagnosis and management of mumps",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?2/38/2663?source=related_link\">",
"      Evaluation of scrotal pain or swelling in children and adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?27/62/28646?source=related_link\">",
"      Management of Henoch-Sch&ouml;nlein purpura (IgA vasculitis)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?0/44/712?source=related_link\">",
"      Neonatal testicular torsion",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?21/3/21561?source=related_link\">",
"      Overview of inguinal hernia in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?18/30/18914?source=related_link\">",
"      Patient information: Epididymitis (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?42/23/43384?source=related_link\">",
"      Procedural sedation in children outside of the operating room",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f31_39_32377="Light microscopy of acute tubular necrosis I";
var content_f31_39_32377=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEPH%2F72453%7ENEPH%2F51526&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEPH%2F72453%7ENEPH%2F51526&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Light microscopy of acute tubular necrosis I",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 378px; height: 255px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Light micrograph in acute tubular necrosis showing focal loss of tubular epithelial cells (arrows) and partial occlusion of tubular lumens by cellular debris (D).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Helmut Rennke, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Light microscopy of acute tubular necrosis II",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 328px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Light micrograph in recovery phase of acute tubular necrosis showing multiple mitoses (arrows) indicative of regenerating tubular cells.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Helmut Rennke, MD",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f31_39_32377=[""].join("\n");
var outline_f31_39_32377=null;
var title_f31_39_32378="Pathogenesis of idiopathic pulmonary fibrosis";
var content_f31_39_32378=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Pathogenesis of idiopathic pulmonary fibrosis",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?31/39/32378/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?31/39/32378/contributors\">",
"     Ganesh Raghu, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?31/39/32378/contributors\">",
"     A S Narayanan, PhD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?31/39/32378/contributors\">",
"     Nasreen Khalil, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?31/39/32378/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?31/39/32378/contributors\">",
"     Talmadge E King, Jr, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?31/39/32378/contributors\">",
"     Andrew Nicholson, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?31/39/32378/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?31/39/32378/contributors\">",
"     Helen Hollingsworth, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?31/39/32378/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Feb 1, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Idiopathic pulmonary fibrosis (IPF), previously known as cryptogenic fibrosing alveolitis (CFA) in Europe, is a chronic, relentlessly progressive fibrotic disorder of the lower respiratory tract that typically affects adults over the age of 40 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32378/abstract/1\">",
"     1",
"    </a>",
"    ]. Idiopathic interstitial pneumonias (IIP) are diffuse parenchymal lung diseases, of which IPF is the most common type of fibrotic lung disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32378/abstract/1,2\">",
"     1,2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The histopathologic pattern associated with the clinical diagnosis of IPF is referred to as \"usual interstitial pneumonia\" (UIP). UIP can also be seen in other fibrotic lung diseases associated with connective tissue disorders, chronic hypersensitivity pneumonitis, and asbestosis. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?18/49/19222?source=see_link\">",
"     \"Classification and clinical manifestations of hypersensitivity pneumonitis (extrinsic allergic alveolitis)\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?16/5/16472?source=see_link\">",
"     \"Asbestosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    An overview of the pathogenesis of IPF, including the central role of fibroblast proliferation and abnormal collagen metabolism will be presented here. The clinical manifestations, differential diagnosis, evaluation, and treatment of IPF are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?22/20/22856?source=see_link\">",
"     \"Approach to the adult with interstitial lung disease: Clinical evaluation\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?16/18/16681?source=see_link\">",
"     \"Approach to the adult with interstitial lung disease: Diagnostic testing\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?33/60/34762?source=see_link\">",
"     \"Treatment of idiopathic pulmonary fibrosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     HISTOPATHOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The characteristic histopathologic features of UIP in patients with IPF include abnormal proliferation of mesenchymal cells, varying degrees of fibrosis, overproduction and disorganized deposition of collagen and extracellular matrix, distortion of pulmonary architecture and subpleural cystic airspaces (3 to 10 mm diameter) called honeycomb cysts. Fibroblast foci are clusters of fibroblasts and myofibroblasts that lie in continuity with the established fibrosis and are a characteristic histologic feature of UIP (",
"    <a class=\"graphic graphic_picture graphicRef58242 \" href=\"mobipreview.htm?36/33/37398\">",
"     picture 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32378/abstract/1,3-6\">",
"     1,3-6",
"    </a>",
"    ]. These abnormalities are typically associated with a mild, patchy chronic inflammatory cell infiltrate.",
"   </p>",
"   <p>",
"    The end result of the fibrotic process is a complex reticulum that is highly interconnected and extends from pleura into the underlying parenchyma [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32378/abstract/7\">",
"     7",
"    </a>",
"    ] (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef71960 \" href=\"mobipreview.htm?28/55/29552\">",
"     image 1",
"    </a>",
"    ). The pathology of UIP in comparison with other interstitial pneumonias is discussed in greater detail separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?4/23/4474?source=see_link&amp;anchor=H3#H3\">",
"     \"Idiopathic interstitial pneumonias: Clinical manifestations and pathology\", section on 'Usual interstitial pneumonia'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     ANIMAL MODELS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Much of the research into mechanisms of disease pathogenesis in IPF comes from work with animal models of pulmonary fibrosis (eg, intratracheal instillation of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?38/15/39159?source=see_link\">",
"     bleomycin",
"    </a>",
"    ). Unfortunately, animal models of lung fibrosis do not translate perfectly to human IPF because most animal models have a prominent inflammatory cellular component as a tissue response to injury. By comparison, UIP, which is the characteristic histological pattern of human IPF, lacks inflammatory cells in the fibrotic lungs [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32378/abstract/1-6\">",
"     1-6",
"    </a>",
"    ]. Subepithelial fibroblast foci, the histological hallmark of UIP, are (",
"    <a class=\"graphic graphic_picture graphicRef58242 \" href=\"mobipreview.htm?36/33/37398\">",
"     picture 1",
"    </a>",
"    ) absent in most animal models of pulmonary fibrosis. Nevertheless, there are sufficient similarities between some animal models and human disease to be able to develop a number of insights and hypotheses about IPF pathogenesis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32378/abstract/8,9\">",
"     8,9",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     INITIATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The precise factors that initiate the histopathologic processes observed in IPF are unknown. Certain risk factors are associated with IPF, including cigarette smoking, viral infection, environmental pollutants, chronic aspiration, genetic predisposition, and drugs [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32378/abstract/10,11\">",
"     10,11",
"    </a>",
"    ]. However, none of these risk factors adequately explains the extensive remodeling and progressive nature of IPF, or the increase in incidence of fibrosis with advancing age.",
"   </p>",
"   <p>",
"    It is possible that nonspecific injury to the epithelial barrier and pulmonary parenchyma, such as might be inflicted by these risk factors, initiates the disease process of IPF in susceptible individuals.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Genetic predisposition",
"    </span>",
"    &nbsp;&mdash;&nbsp;A genetic predisposition to pulmonary fibrosis is suggested by reports of families with several affected members (familial pulmonary fibrosis) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32378/abstract/3,10,12-25\">",
"     3,10,12-25",
"    </a>",
"    ]. However, the precise genetic and host susceptibility factor(s) that determine the phenotypic expression and clinical manifestations of sporadic IPF remain unknown [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32378/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Investigations have identified several gene mutations that may play a role in the pathogenesis of pulmonary fibrosis:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Mutations in surfactant proteins A2 (SP-A2) and C (SFTPC) have been identified in several families with IPF [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/39/32378/abstract/16-18\">",
"       16-18",
"      </a>",
"      ]. Mutations in the adenosine triphosphate binding cassette A3 (ABCA3) gene may affect the course of SFTPC-related IPF [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/39/32378/abstract/14,19\">",
"       14,19",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      A genome-wide linkage scan identified a risk locus for IPF on chromosome 11, and further fine mapping of that locus found a common variant in the promoter of the gene encoding mucin 5B (MUC5B) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/39/32378/abstract/20\">",
"       20",
"      </a>",
"      ].This variant was present in 34 percent of subjects with familial pulmonary fibrosis, 38 percent of those with IPF, and 9 percent of controls. MUC5B expression in lung tissue is 14 times higher in subjects with IPF, compared with unaffected subjects.",
"     </li>",
"     <li>",
"      Telomerase gene mutations, which cause shortened telomeres, have been identified in about 25 percent of sporadic IPF and in about 15 percent of families with familial pulmonary fibrosis [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/39/32378/abstract/21-25\">",
"       21-25",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Inflammation",
"    </span>",
"    &nbsp;&mdash;&nbsp;It was previously postulated that inflammation preceded fibrosis in IPF, based upon the following observations:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In animal models, inflammation precedes the development of a fibrotic response, and suppression of the inflammatory alveolitis attenuates the subsequent fibrotic response [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/39/32378/abstract/26\">",
"       26",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Histologically, the alveolitis of early pulmonary fibrosis in animal models is dominated by inflammatory cells, including alveolar macrophages, neutrophils, eosinophils, and lymphocytes. Increased numbers of basophils and mast cells also have been described [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/39/32378/abstract/27\">",
"       27",
"      </a>",
"      ]. It is not known whether this pertains to human UIP.",
"     </li>",
"     <li>",
"      Asymptomatic relatives of patients with a familial form of IPF have cellular evidence of alveolitis in the absence of clinically recognizable disease [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/39/32378/abstract/28\">",
"       28",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Some patients with chronic hypersensitivity pneumonitis have UIP on lung biopsy. Presumably, an inflammatory phase preceded the fibrotic phase.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The alveolar macrophage was proposed to play a pivotal role in the genesis of IPF due to its ability to secrete proinflammatory and profibrotic cytokines that affect mesenchymal cell proliferation and promote collagen deposition [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32378/abstract/3,9\">",
"     3,9",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The above postulate that lung inflammation is necessary and sufficient to produce fibrosis in IPF has been questioned for several reasons [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32378/abstract/29\">",
"     29",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Inflammation is generally minimal in patients with IPF, and there is no evidence that patients with early disease have more prominent inflammatory changes [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/39/32378/abstract/1,5\">",
"       1,5",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Fibrosis can be induced in laboratory animals in the absence of inflammation [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/39/32378/abstract/8\">",
"       8",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Antiinflammatory therapy with systemic glucocorticoids has failed to alter the natural history of IPF.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Fibroblast and epithelial cell dysfunction",
"    </span>",
"    &nbsp;&mdash;&nbsp;Another theory is that IPF results from aberrant fibroblast and epithelial cell function and abnormal epithelial-mesenchymal interactions with little or no inflammatory component [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32378/abstract/29\">",
"     29",
"    </a>",
"    ]. This view is supported by the presence of fibrotic foci in areas of disrupted basement membrane directly beneath areas of damaged epithelium without the presence of a significant inflammatory cell infiltrate [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32378/abstract/30-32\">",
"     30-32",
"    </a>",
"    ]. Initiation and perpetuation of this fibrotic response may depend upon genetic factors, environmental triggers, and imbalance of oxidants and antioxidants; imbalance of Th1 and Th2 cell-derived cytokines may also be important [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32378/abstract/33-36\">",
"     33-36",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H10\">",
"     'Mechanisms of fibrosis'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     PERPETUATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;A critical element in the pathogenesis of IPF is the unremitting fibrotic response; many patients with",
"    <span class=\"nowrap\">",
"     IPF/UIP",
"    </span>",
"    have moderate to advanced fibrotic disease at the time of diagnosis without histologic evidence of cellular inflammation in the pulmonary parenchyma. This differs from inflammatory pulmonary conditions such as bacterial pneumonia, in which massive pulmonary inflammation is followed by recovery with minimal long-term effects on lung structure and function. The stimulus that promotes pulmonary fibrosis instead of repair is unknown. If inflammation is an essential component of IPF, the mechanisms involved in the clearance of acute inflammation may be impaired [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32378/abstract/34,35,37\">",
"     34,35,37",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In some animal models of pulmonary fibrosis, inflammation is followed by recovery, and fibrosis does not progress. For example, following intratracheal instillation of the fifth component of complement, there is a massive influx of neutrophils and monocytes within 24 hours [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32378/abstract/35\">",
"     35",
"    </a>",
"    ]. Similarly, intratracheal instillation of the anti-neoplastic antibiotic,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?38/15/39159?source=see_link\">",
"     bleomycin",
"    </a>",
"    , leads to an initial injury to the alveolar epithelium and an influx of activated macrophages and neutrophils into alveoli that resolves in two to four weeks [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32378/abstract/35,37,38\">",
"     35,37,38",
"    </a>",
"    ]. However, monocytes persist in alveolar walls up to eight weeks after exposure, at which time the histology is predominantly fibrotic [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32378/abstract/35\">",
"     35",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     PROGRESSION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Another characteristic feature of IPF is that the fibrotic process is progressive. Once initiated at the epithelial barrier of the alveoli, the injury to epithelial cells and basement membrane results in complex cell and cytokine interactions that extend the fibrotic process to involve the alveolar walls, alveolar lumen, and then adjacent areas of lung parenchyma.",
"   </p>",
"   <p>",
"    An early consequence of injury to the epithelium is development of an intraalveolar exudate. Organization of the intraalveolar exudate leads to alveolar collapse with apposition of the denuded alveolar walls and loss of surfactant [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32378/abstract/39\">",
"     39",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Both epithelial and basement membrane injury appear necessary for the development of intraluminal fibrosis. In the normal lung, the alveolar epithelium is comprised predominantly of type I epithelial cells, with a relatively small number of type II epithelial cells [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32378/abstract/40\">",
"     40",
"    </a>",
"    ]. Following injury, type II cells proliferate and differentiate into type I cells, and are normally responsible for reepithelialization of injured alveoli [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32378/abstract/41\">",
"     41",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In IPF, loss of epithelial type I cells and marked proliferation of epithelial type II cells are noted; however, these cells do not appear to reepithelialize the alveolar space in IPF [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32378/abstract/42\">",
"     42",
"    </a>",
"    ]. This may be due to continued abnormalities of the basement membrane, which has microscopic alterations including duplication and fragmentation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32378/abstract/39\">",
"     39",
"    </a>",
"    ]. These basement membrane abnormalities in turn permit the migration of mesenchymal cells from the interstitium to the alveolar regions of the injured lung [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32378/abstract/31\">",
"     31",
"    </a>",
"    ]. Excessive deposition of collagen by mesenchymal cells appears to prevent reexpansion of the collapsed airspace. The pattern of these changes suggests that chronic or recurrent injury to the alveolar epithelium may result in the progressive nature of intraalveolar exudates, fibrosis, and remodeling.",
"   </p>",
"   <p>",
"    It is also possible that an initial injury and release of cytokines leads to long lasting effects on fibroblasts. For example, in an experimental model of IPF the release of transforming growth factor-beta1 (TGF-&beta;1) from alveolar epithelial cells for 4 days led to induction of fibroblast growth factor (FGF)-2, which was sequestered in the fibroblast matrix and led to an altered fibroblast phenotype with continued proliferation long after the exposure to TGF-&beta;1 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32378/abstract/43\">",
"     43",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In patients with IPF, serum concentrations of lung surfactant proteins (SP-A and SP-D) and Kerbs von Lungren 6 antigen (KL-6) are increased, and changes in serum concentration of KL-6 may be a marker for disease activity [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32378/abstract/44,45\">",
"     44,45",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     MECHANISMS OF FIBROSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The mechanism of fibrosis in IPF remains elusive; however, a number of likely contributors have been identified (",
"    <a class=\"graphic graphic_figure graphicRef64611 \" href=\"mobipreview.htm?6/32/6662\">",
"     figure 1",
"    </a>",
"    ). It is possible that multiple microinjuries to alveolar epithelial cells induce a fibrotic environment, and that growth factors secreted by the injured epithelial cells recruit fibroblasts that differentiate into myofibroblasts. Myofibroblasts are cells that express features of both fibroblasts and smooth muscle cells, and are identified by their expression of alpha-smooth muscle actin (SMA) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32378/abstract/42\">",
"     42",
"    </a>",
"    ]. After being recruited to the lungs or differentiated from resident fibroblasts, myofibroblasts secrete collagen, which accumulates due to imbalance between interstitial collagenases and their tissue inhibitors [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32378/abstract/29\">",
"     29",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    While recurrent microinjuries to the alveolar wall and distal airways seem to be necessary for the initiation of fibrosis, specific extrinsic factors that might contribute to epithelial injury have not been identified. Since 90 percent of patients with IPF have physiologically detectable gastroesophageal reflux, often in the absence of symptoms, it is conceivable that microaspiration of acid into the distal lungs could be one cause of recurrent insults to epithelial barrier, altered epithelial-mesenchymal interactions, and subsequent fibrosis in genetically predisposed individuals. Further studies are required to determine if a causal relationship exists between gastroesophageal reflux and IPF.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Altered reepithelialization",
"    </span>",
"    &nbsp;&mdash;&nbsp;A considerable body of evidence suggests a critical role for alveolar epithelial cells (AEC) in the pathogenesis of IPF [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32378/abstract/32,46\">",
"     32,46",
"    </a>",
"    ]. Electron microscope studies demonstrate that resident mesenchymal cells are located in the space between the alveolar epithelium and the capillary endothelium [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32378/abstract/47\">",
"     47",
"    </a>",
"    ]. The close proximity of mesenchymal cells to epithelial cells may contribute to the regulation of cell proliferation and connective tissue synthesis by fibrogenic cytokines released from epithelial cells. The current hypothesis suggests that repeated subclinical injury to the lung injures the alveolar epithelial, the subepithelial, and adjacent endothelial basement membranes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32378/abstract/32\">",
"     32",
"    </a>",
"    ]. This injury permits entry into the alveoli of cells of the mesenchymal lineage, and also other cells and cytokines. Eventually, based on a complex integrated process that is poorly understood, there is the emergence of a phenotype of fibroblasts that are highly, active, proliferative and contractile.",
"   </p>",
"   <p>",
"    In IPF, there is loss of type I epithelial cells and proliferation of type II cells; orderly reepithelialization followed by differentiation of the type II cells to type I AECs does not occur [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32378/abstract/41\">",
"     41",
"    </a>",
"    ]. This lack of normal reepithelialization may, in part, be due to an aberrant activation of the Wnt signaling pathway following to lung injury [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32378/abstract/47\">",
"     47",
"    </a>",
"    ]. The Wnt proteins inhibit phosphorylation of beta-catenin by glycogen synthase kinase 3b (GSK3b), and prevent its translocation to nucleus and activation of the lymphoid enhancing",
"    <span class=\"nowrap\">",
"     factor/T-cell",
"    </span>",
"    factor",
"    <span class=\"nowrap\">",
"     (LEF/TCF)",
"    </span>",
"    transcription factors; this is believed to activate proliferation of type II calls and inhibit their differentiation, with eventual triggering of divergent epithelial regeneration at bronchoalveolar junctions and possibly leading to epithelial-mesenchymal transformation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32378/abstract/48\">",
"     48",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Another possible abnormality of the alveolar epithelium in IPF patients is impaired regenerative capacity of the epithelium. In some IPF patients the impaired regeneration could be genetic or age related. For example, in a cohort of familial IPF patients there is dysfunctional telomerase shortening, which may lead to cellular senescence and poor reepithelialization, either after an injury or after natural cell turn-over. (See",
"    <a class=\"local\" href=\"#H5\">",
"     'Genetic predisposition'",
"    </a>",
"    above.) It then follows that IPF patients maybe a subset of genetically susceptible individuals, in whom epithelial regeneration may become impaired with advancing age [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32378/abstract/49\">",
"     49",
"    </a>",
"    ]. This speculation fits with observation of increase in incidence and prevalence of IPF with advancing age [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32378/abstract/49\">",
"     49",
"    </a>",
"    ]. Another well recognized aberrancy of the AEC in IPF patients may be the overproduction and release of fibrogenic cytokines and growth factors.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Cytokines, growth factors, and other molecules",
"    </span>",
"    &nbsp;&mdash;&nbsp;While the exact nature of the initiating injury and the subsequent cascade of mechanistic events needs to be elucidated, it is now clear that the interaction of growth factors, cytokines, and other mediators with cells resident in the lung is important to the evolution of the fibrotic response in IPF (",
"    <a class=\"graphic graphic_figure graphicRef64611 \" href=\"mobipreview.htm?6/32/6662\">",
"     figure 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32378/abstract/50-52\">",
"     50-52",
"    </a>",
"    ]. Resident epithelial cells, fibroblasts, and endothelial cells within the lung produce an array of cytokines and growth factors that stimulate fibroblast proliferation and matrix synthesis. Following epithelial injury, fibrosis is believed to progress due to an imbalance between many groups of molecules that include proinflammatory and antiinflammatory cytokines, fibrogenic and antifibrogenic polypeptides, oxidants-antioxidants, and angiogenic and angiostatic molecules [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32378/abstract/51,53\">",
"     51,53",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Unlike bronchoalveolar lavage (BAL) from normal controls, BAL from patients with IPF contains increased amounts of transforming growth factor-beta (TGF-beta), including the active form TGF-beta1 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32378/abstract/54,55\">",
"     54,55",
"    </a>",
"    ]. TGF-beta1 is one of the most potent regulators of connective tissue synthesis due to its ability to increase connective tissue synthesis, down-regulate connective tissue proteases, and increase the inhibitors of connective tissue proteases [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32378/abstract/54,56\">",
"     54,56",
"    </a>",
"    ]. TGF-beta1 can also induce a number of growth factors and cytokines that participate in fibrosis, including connective tissue growth factor (CTGF), fibroblast growth factor (FGF-2), platelet derived growth factor (PDGF), insulin-like growth factor (IGF), and interleukins (ILs) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32378/abstract/51,57\">",
"     51,57",
"    </a>",
"    ]. The role of TGF-beta in IPF is supported by inhibition of fibrosis in experimental animals by reducing its expression, signaling, and activity.",
"   </p>",
"   <p>",
"    CTGF is a downstream mediator of TGF-beta1; it influences connective tissue synthesis by fibroblasts and functions as a mitogen for cells independently or in association with other mediators. CTGF expression is increased in bronchoalveolar lavage of patients with IPF [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32378/abstract/57,58\">",
"     57,58",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Another cytokine implicated in IPF is tumor necrosis factor-alpha (TNF-alpha). TNF-alpha expression is increased in IPF, but its specific role is not clear. TNF-alpha has the ability to increase production of TGF-beta1 and other peptide mediators, stimulate fibroblast proliferation, and induce collagen synthesis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32378/abstract/59,60\">",
"     59,60",
"    </a>",
"    ]. Among individuals with TNF-alpha gene polymorphisms, there is an increased risk of developing IPF [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32378/abstract/61\">",
"     61",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In contrast, expression of interferon-gamma (IFN-gamma), an inhibitor of fibroblast proliferation and connective tissue synthesis, appears to be deficient in lungs from patients with IPF [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32378/abstract/62-65\">",
"     62-65",
"    </a>",
"    ]. IFN-gamma also suppresses the Th2-type inflammatory response. While these observations suggested a potential therapeutic role for IFN-gamma, treatment with subcutaneous humanized",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?19/53/20308?source=see_link\">",
"     interferon gamma-1b",
"    </a>",
"    did not reduce mortality among patients with IPF [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32378/abstract/66\">",
"     66",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In IPF, there is also an overexpression of fibrotic cytokines. The putative role of chemokines such as monocyte chemoattractant protein 1 (MCP-1) in the recruitment of IPF cells is becoming increasingly recognized. TGF-beta, CTGF, IL-4, IL-13, FGF-2, IGF-1, PDGF and GM-CSF are fibrogenic and IFN-gamma, IL-1, IL-10, IL-12, IL-17 are anti-fibrogenic molecules. Evolution of fibrosis appears to involve the activator protein (AP)-1 transcription factor and the fos-related protein Fra-2 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32378/abstract/67\">",
"     67",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Additional proteins that may contribute to pathogenesis or reflect disease activity of IPF have been identified using gene expression profiles [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32378/abstract/68-73\">",
"     68-73",
"    </a>",
"    ]. As an example, genes over expressed in lung tissue and blood from patients with IPF include matrix metalloprotein (MMP)-7, MMP-1, surfactant protein A1, cyclin A2 (CCNA2), and alpha-defensins [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32378/abstract/70-72\">",
"     70-72",
"    </a>",
"    ]. Comparing gene expression profiles from IPF lungs with profiles of genes associated with lung development may provide insight into the pathogenic mechanisms [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32378/abstract/68,69\">",
"     68,69",
"    </a>",
"    ]. Furthermore, a signature of increased MMP-7 and MMP-1 has been noted in the peripheral blood of patients with IPF and levels of these proteins may correlate with disease activity [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32378/abstract/73\">",
"     73",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Fibrotic foci",
"    </span>",
"    &nbsp;&mdash;&nbsp;Fibrotic foci are now recognized as the characteristic histological feature of UIP (",
"    <a class=\"graphic graphic_picture graphicRef58242 \" href=\"mobipreview.htm?36/33/37398\">",
"     picture 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32378/abstract/1,6\">",
"     1,6",
"    </a>",
"    ]. Following the induction of fibroblast activity by epithelial injury, fibroblasts and myofibroblasts appear to organize into fibrotic foci that precede the appearance of end-stage fibrosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32378/abstract/30\">",
"     30",
"    </a>",
"    ]. These fibroblast foci are situated adjacent to sites of epithelial cell and basement membrane damage, and consist of aggregates of actively proliferating fibroblasts and myofibroblasts.",
"   </p>",
"   <p>",
"    The persistence of fibroblasts and formation of fibroblast foci may be regulated by inhibition of apoptosis of fibroblasts. For example, IL-4 has been shown to induce macrophage derived insulin-like growth factor-1 (IGF-1) and inhibit IPF fibroblast apoptosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32378/abstract/74\">",
"     74",
"    </a>",
"    ]. In another study, pigment epithelium-derived factor (PEDF), a 50 kDa protein, was expressed in fibroblasts of IPF lungs, indicating its possible role in apoptosis and maintenance of fibroblasts [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32378/abstract/75\">",
"     75",
"    </a>",
"    ]. These cells also express different intermediate filaments than fibroblasts; however, the pattern of expression varies in different tissues and under different pathological conditions.",
"   </p>",
"   <p>",
"    Fibroblasts differentiate into myofibroblasts under the influence of transforming growth factor beta (TGF-beta), which results in expression of alpha smooth muscle actin (SMA), increased collagen production, and decreased synthesis of tissue inhibitor of metalloproteinase 2 (TIMP-2) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32378/abstract/76-78\">",
"     76-78",
"    </a>",
"    ]. Fibrotic foci can be identified by the presence of proliferating myofibroblasts that are actively synthesizing collagen [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32378/abstract/3,76\">",
"     3,76",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Soluble mediators secreted by alveolar epithelial cells and other cells in the surrounding milieu are believed to induce leukocyte influx, stimulate fibroblast activity, and promote fibrosis. Important among these are TGF-beta, TNF-alpha, and interleukin (IL)-8. TGF-beta is produced by activated epithelial cells, macrophages, and endothelial cells, and is the most crucial mediator in the development of pulmonary fibrosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32378/abstract/54,56\">",
"     54,56",
"    </a>",
"    ]. It is elevated both in patients with IPF and following intratracheal instillation of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?38/15/39159?source=see_link\">",
"     bleomycin",
"    </a>",
"    in the murine model of IPF. In addition, fibrosis is attenuated by the inhibition of TGF-beta [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32378/abstract/79,80\">",
"     79,80",
"    </a>",
"    ]. Specific polymorphisms of the gene encoding TGF-beta appear to increase the risk of disease progression [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32378/abstract/81\">",
"     81",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Mesenchymal cells",
"    </span>",
"    &nbsp;&mdash;&nbsp;The mesenchymal cell population at the site of fibrotic foci (",
"    <a class=\"graphic graphic_picture graphicRef58242 \" href=\"mobipreview.htm?36/33/37398\">",
"     picture 1",
"    </a>",
"    ) includes fibroblasts, myofibroblasts, pericytes, smooth muscle cells, and undifferentiated cells [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32378/abstract/82\">",
"     82",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The fibroblasts at these foci could be derived from four sources: interstitial peribronchiolar and perivascular adventitial fibroblasts, epithelial cells, circulating fibrocytes, and bone marrow-derived marrow stem cells [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/39/32378/abstract/83\">",
"       83",
"      </a>",
"      ]. These cells are located predominantly within alveolar walls.",
"     </li>",
"     <li>",
"      Myofibroblasts, which are present in wound granulation tissue and have morphologic features of both fibroblasts and smooth muscle cells, are derived from fibroblasts and epithelial cells. (See",
"      <a class=\"local\" href=\"#H20\">",
"       'Myofibroblasts'",
"      </a>",
"      below.)",
"     </li>",
"     <li>",
"      Smooth muscle cells are located within the walls of the airways and blood vessels.",
"     </li>",
"     <li>",
"      Pericytes are distributed along the pulmonary capillaries. However, their role in IPF is not known.",
"     </li>",
"     <li>",
"      Contractile interstitial cells (CICs) are located predominantly within the alveolar walls and share ultrastructural features with myofibroblasts. They are abundant in the normal lung. One study using ultrastructural morphometry found that CICs account for 42 percent of the interstitial lung volume and comprise 18 percent of all lung parenchymal cells [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/39/32378/abstract/84\">",
"       84",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    These same populations of cells are present in patients with IPF, but their proportion is greater than in the normal lung. As an example, one study found that IPF lungs demonstrated a 1.8-fold increase in the proportion of parenchymal cells that were mesenchymal in origin, and that these cells proliferated at a faster rate in the IPF lung than in the normal lung. These alterations were most pronounced in the fibroblast populations with altered phenotypes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32378/abstract/74,76,77\">",
"     74,76,77",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Fibroblast subtypes",
"    </span>",
"    &nbsp;&mdash;&nbsp;IPF is characterized by fibroblast subpopulations that differ in their behavior when compared to fibroblasts isolated from normal lungs. These differences include altered proliferative potential, distinctive gene and cell surface marker expression, and dissimilar cell-mediated responses [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32378/abstract/36\">",
"     36",
"    </a>",
"    ]. Whether these differences occur as a primary phenomenon, or are secondary to prolonged exposure to an inflammatory milieu, is presently unclear. It appears that these changes are important in transforming the fibroblast from a relatively passive cell into an important factor in the pathogenesis of IPF [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32378/abstract/85\">",
"     85",
"    </a>",
"    ]. Regardless of the phenotypic differences, the fibroblast-like cell is the key target-effector cell that appears to determine the fibrotic response in IPF [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32378/abstract/82\">",
"     82",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Beyond identification of distinct lung mesenchymal cell populations based upon expression of protein microfilaments, lung fibroblast subsets have been separated according to their expression of membrane proteins. Two examples of such cell surface protein markers, which show distinct differences in proliferation rate, collagen deposition and morphology, are the thymocyte 1 antigen (Thy 1) and the complement 1q (C1q) receptor [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32378/abstract/86,87\">",
"     86,87",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h3\">",
"     Thymocyte 1 antigen subtypes",
"    </span>",
"    &nbsp;&mdash;&nbsp;Murine and rat lung fibroblasts have been separated on the basis of thymocyte 1 (Thy 1) antigen expression or absence using fluorescence activated cell sorting (FACS) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32378/abstract/86,88\">",
"     86,88",
"    </a>",
"    ]. The fibroblast subsets (ie, Thy 1(-) and Thy 1(+)) retain their differences in Thy 1 expression over several weeks in culture. Thy 1(-) fibroblasts spread over a greater area and contain a more extensive microfilament network, while the Thy 1(+) fibroblasts were lipid containing. Only the Thy 1(-) cells demonstrated expression of the class II MHC antigen (1a) following treatment with interferon-gamma (IFN-gamma) and were capable of presenting antigen to T lymphocyte clones.",
"   </p>",
"   <p>",
"    Murine populations of Thy 1(+) and Thy 1(-) lung fibroblasts, separated using FACS and studied in vitro, demonstrate remarkable behavioral differences in regard to IL-4 induced collagen synthesis, proliferation response to PDGF-AA, and stimulation by TNF-alpha [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32378/abstract/88\">",
"     88",
"    </a>",
"    ]. In addition, the percentage of Thy 1(+) lung fibroblasts cultured from injured lungs was found to vary between two rat strains that demonstrated different propensity for the development of experimentally induced lung fibrosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32378/abstract/89\">",
"     89",
"    </a>",
"    ]. For example, Thy 1(-) lung fibroblasts treated with fibrogenic cytokines PDGF, interleukin (IL)-1B, and IL-14 respond to TGF-beta mediated signaling better than Thy 1(+) cells [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32378/abstract/90\">",
"     90",
"    </a>",
"    ]. Further studies will be required to determine the precise role Thy 1 fibroblast subtypes play in the pathogenesis of lung fibrosis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h3\">",
"     C1q receptor subtypes",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cell culture media conditions can be manipulated to enhance the growth of normal human lung-derived fibroblast cell populations with varying C1q binding affinity. High and low fluorescence (HF and LF, respectively) anti-C1q antibody binding populations were sorted using FACS, and these cells maintained their respective fluorescent phenotypes after subculture [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32378/abstract/87\">",
"     87",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A variety of behavioral differences among these subtypes have been noted. These include differences in proliferation potential and type I collagen mRNA expression both under steady state conditions, and in response to TGF-beta 1 and IFN-gamma. Other studies have shown that a 51 kDa protein that binds the C1q-globular domain is found mostly in the HF cells. In contrast, the receptor for the C1q-collagen domain is produced largely by the LF fibroblasts [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32378/abstract/91\">",
"     91",
"    </a>",
"    ]. These studies support the belief that lung fibroblast subtypes have varying rates of proliferation and collagen synthesis, and that these population differences may have relevance to the pathogenesis of fibroproliferative lung disease in general.",
"   </p>",
"   <p>",
"    More definitive evidence that fibroblast subtypes can be identified at the gene level was obtained by the isolation of mRNA, which is expressed at high levels in HF fibroblasts, and only marginally in LF cells [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32378/abstract/92\">",
"     92",
"    </a>",
"    ]. This mRNA, called LR8, was not detected in cultures of other cell types. The expression of LR8 appears to be upregulated in human IPF lungs and mouse lungs with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?38/15/39159?source=see_link\">",
"     bleomycin",
"    </a>",
"    -induced fibrosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32378/abstract/92\">",
"     92",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Circulating fibrocytes",
"    </span>",
"    &nbsp;&mdash;&nbsp;Fibrocytes found in the circulation are hematopoietic in origin [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32378/abstract/93,94\">",
"     93,94",
"    </a>",
"    ]. These comprise 0.1 to 0.5 percent of circulating leukocyte population and are defined by expression of type I collagen (Col1), CD11b, CD13, CD34, CR45RO, MHCII, and CD86. Circulating fibrocytes are believed to bind to CCR7 and CXCR4 receptors in injured lung tissue under the influence of chemokines CCL21 and CXC chemokine ligand 12 (CXCL12). When cultured, the fibrocytes express connective tissue proteins and can differentiate into myofibroblasts, suggesting that fibrocytes could differentiate into myofibroblasts in IPF [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32378/abstract/93,94\">",
"     93,94",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Evidence for potential involvement of circulating fibrocytes in IPF includes induction of chemokines CCL21 and CXCL12 in",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?38/15/39159?source=see_link\">",
"     bleomycin",
"    </a>",
"    -induced pulmonary fibrosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32378/abstract/93\">",
"     93",
"    </a>",
"    ]. As an example, influx of circulating fibrocytes (CD45+Col+CXCR4+) was demonstrated in the lungs of bleomycin-treated SCID mice; this influx could be partially inhibited by CXCL12 specific antibodies [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32378/abstract/93\">",
"     93",
"    </a>",
"    ]. These fibrocytes contributed significantly to the increase in collagen synthesis seen in this model [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32378/abstract/93\">",
"     93",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Circulating fibrocytes are normally alpha-SMA negative, but become positive over time in culture; this capacity is increased by TGF-beta. The presence of cells expressing Col1, alpha-SMA, and CD34+ in bronchial mucosa of asthma patients supports the role of circulating fibrocytes in humans [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32378/abstract/95\">",
"     95",
"    </a>",
"    ]. The role of the circulating fibrocyte in the pathogenesis of IPF is unclear. Further studies are needed to clarify their contribution and to determine if the number of circulating fibrocytes varies during different stages of IPF (eg, acute exacerbation of IPF, stable disease, progressive disease).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Fibroblast proliferation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Lung biopsies from patients with IPF show an increase in the number of fibroblasts. The increase is largely due to increased proliferation. Evidence for this comes from observations of fibroblasts derived from patients with IPF and studied in vitro. As examples:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The most consistent, though not universal, characteristic observed in fibroblasts isolated from IPF lungs is their augmented ability to proliferate either in vivo or in vitro [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/39/32378/abstract/82,96,97\">",
"       82,96,97",
"      </a>",
"      ]. In addition, they are relatively resistant to the antiproliferative effect of prostaglandin E2 (PGE2), have a diminished capacity to synthesize PGE2, and do not upregulate their inducible cyclooxygenase activity in response to a variety of agonists [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/39/32378/abstract/98,99\">",
"       98,99",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      One study examined fibroblast cell lines isolated from normal controls, from patients during an early cellular stage of fibrosis, and from patients during a late stage of dense fibrosis [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/39/32378/abstract/97\">",
"       97",
"      </a>",
"      ]. Under standardized and serum-free culture conditions, 55 percent of the normal cells were cycling when cultured, compared to 85 percent of the cells from early stage fibrosis and 31 percent from the late stage of fibrosis. These conflicting results regarding differences in the in vitro proliferative characteristics of fibroblasts from normal and fibrotic lungs may be related to the stage of the fibrotic process.",
"     </li>",
"     <li>",
"      Tritiated thymidine uptake, a reflection of DNA replication, has been found to be increased in acute interstitial pneumonia [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/39/32378/abstract/100\">",
"       100",
"      </a>",
"      ], suggesting that increases in fibroblast-like cell numbers in fibrotic lesions arise from proliferation of local mesenchymal cell populations. A time course study of paraffin-embedded lung tissue sections from rats exposed to",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?38/15/39159?source=see_link\">",
"       bleomycin",
"      </a>",
"      supports the role of local mesenchymal cell proliferation in the pathogenesis of fibroproliferative lung lesions [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/39/32378/abstract/101\">",
"       101",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Myofibroblasts",
"    </span>",
"    &nbsp;&mdash;&nbsp;Myofibroblasts produce interstitial collagens in significantly greater amounts than fibroblast-like cells [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32378/abstract/42,76,102\">",
"     42,76,102",
"    </a>",
"    ]. Two main sources of myofibroblasts in IPF have been identified. It is believed that fibroblasts differentiate into myofibroblasts under the influence of mediators, such as TGF-beta. In addition, a portion of fibroblasts may arise from mesenchymal transformation of local epithelial cells, as observed in a renal model of fibrosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32378/abstract/103,104\">",
"     103,104",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Transdifferentiation of epithelial cells through epithelial mesenchymal transformation (EMT) is thought to be another source of myofibroblasts [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32378/abstract/104,105\">",
"     104,105",
"    </a>",
"    ]. EMT is a form of metaplasia that has long been known to play a role during tumor progression. Growth factors promoting EMT include TGF-beta, epidermal growth factor (EGF), hepatocyte growth factor (HGF), and fibroblast growth factor (FGF); transcription factors Smads, Slug, Snail, Scatter, lymphoid enhancing factor-1, and beta-catenin are also involved [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32378/abstract/105,106\">",
"     105,106",
"    </a>",
"    ]. In the process of EMT, cells acquire myofibroblast markers (eg, smooth muscle actin [SMA]), fibroblast markers (eg, FSP1), and lose epithelial markers (eg, E-cadherin, zonula occudents-1).",
"   </p>",
"   <p>",
"    Myofibroblast apoptosis is a normal event during resolution of wound-repair, and failure of their apoptosis may also lead to accumulation of myofibroblasts and persistent production of extracellular matrix (ECM) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32378/abstract/107\">",
"     107",
"    </a>",
"    ]. In the rat model of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?38/15/39159?source=see_link\">",
"     bleomycin",
"    </a>",
"    -induced lung fibrosis, both myofibroblast-like cells and fibroblasts were increased in number 14 days after the administration of bleomycin. However, at 28 days post exposure, fibroblast numbers returned to baseline values, while the number of myofibroblast-like cells increased 10-fold when compared to normal lung [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32378/abstract/102\">",
"     102",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Another study reported that 7 and 14 days following",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?38/15/39159?source=see_link\">",
"     bleomycin",
"    </a>",
"    administration, rat lung specimens revealed an increase in two distinct mesenchymal cell populations [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32378/abstract/108\">",
"     108",
"    </a>",
"    ]. One type of mesenchymal cell was located within areas of active fibrosis and demonstrated expression of alpha-SMA, desmin, and procollagen mRNA. The other was predominantly localized within fibrotic submesothelial areas, and expressed only SMA and procollagen mRNA. Using colocalization of SMA and procollagen alpha1(I) mRNA expression, lung myofibroblasts were found to be responsible for the vast majority of collagen synthesis. A similar conclusion regarding the major role of the myofibroblast in collagen accumulation in human fibrotic lung disease was drawn from immunohistochemical analysis of lung biopsy specimens from patients with IPF, acute respiratory distress syndrome, and cryptogenic organizing pneumonia (also known as bronchiolitis obliterans organizing pneumonia) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32378/abstract/109\">",
"     109",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In a",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?38/15/39159?source=see_link\">",
"     bleomycin",
"    </a>",
"    -fibrosis model, overexpression of the gene hyaluronan synthase (produces the extracellular matrix component hyaluronan) and its cognate receptor CD44 promoted the conversion of myofibroblasts into an aggressive and invasive phenotype [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32378/abstract/110\">",
"     110",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The contractile property of myofibroblasts has been demonstrated in vitro using strips of fibrotic lung that contract in response to epinephrine and other agents [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32378/abstract/76\">",
"     76",
"    </a>",
"    ]. In addition, the increased proportion of myofibroblast-like cells correlated with greater contractile properties when cultured on collagen gels. Of note, the cells isolated from",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?38/15/39159?source=see_link\">",
"     bleomycin",
"    </a>",
"    -treated lung also expressed more mRNA for TGF-beta1, and reverted to the phenotype isolated from normal lung when treated with anti-TGF-beta antibodies [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32378/abstract/108\">",
"     108",
"    </a>",
"    ]. As mentioned above, TGF-beta plays a significant role in the proliferation of the myofibroblast phenotype since it induces expression of SMA in lung fibroblasts in culture [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32378/abstract/111\">",
"     111",
"    </a>",
"    ]. A temporal in vivo correlation also has been described between epithelial type II cell TGF-beta 1 expression and SMA expression in lung mesenchymal cells [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32378/abstract/84\">",
"     84",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Using microRNA arrays on IPF lungs some interesting observations have been made. MicroRNAs (miRNAs) are short RNA molecules that contain approximately 22 nucleotides and function to inhibit or promote the degradation of specific target mRNAs. Aberrant expression of the microRNA family miR-21 has been demonstrated in myofibroblasts from IPF lungs, but not from normal controls. The miR-21 has been shown to function like an oncogene and in this manner prevents myofibroblast senescence and promotes proliferation and differentiation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32378/abstract/112\">",
"     112",
"    </a>",
"    ]. In contrast to miR-21, there is diminished expression of miR-29, which inhibits fibrogenic proteins; the diminished expression of miR-29 in IPF lung fibroblasts may result in excessive connective tissue synthesis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32378/abstract/112\">",
"     112",
"    </a>",
"    ]. Taken together these observations suggest that aberrant post-transcriptional gene regulation in fibroblasts of IPF patients may result in a unique phenotype of fibroblasts that proliferate excessively and synthesize connective tissue proteins without control.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h1\">",
"     COLLAGEN DEPOSITION",
"    </span>",
"    &nbsp;&mdash;&nbsp;In idiopathic pulmonary fibrosis (IPF), excess collagen is produced by myofibroblasts and deposited in a disorganized manner within the extracellular matrix.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Normal lungs",
"    </span>",
"    &nbsp;&mdash;&nbsp;Collagen is the predominant type of protein in the extracellular matrix of the lung, constituting 20 percent of the dry weight of normal lungs [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32378/abstract/113\">",
"     113",
"    </a>",
"    ]. The collagen family of triple helical proteins includes approximately 28 variants, which are classified according to their gene structure and alpha chain composition into \"fibril-forming,\" \"fibril associated collagens with interrupted triple helix (FACIT),\" \"network forming,\" and \"transmembrane\" groups [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32378/abstract/114,115\">",
"     114,115",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Normal lung collagen is composed of several different collagen types that are distributed in a cell and location specific manner, including [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32378/abstract/113\">",
"     113",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Types I and III are the predominant isoforms and constitute &gt;90 percent of the total lung collagen. These isoforms are mostly located in the interstitium, within the alveolar wall, and in association with the large bronchi and blood vessels.",
"     </li>",
"     <li>",
"      Type II is present in the cartilage of the central airways.",
"     </li>",
"     <li>",
"      Type IV is present in basement membranes.",
"     </li>",
"     <li>",
"      Type VI is present in the interstitium.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Biosynthesis of collagens involves several biochemical events [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32378/abstract/116\">",
"     116",
"    </a>",
"    ]. Following DNA transcription, collagen mRNA is translated into procollagen alpha chains, which are then modified by the hydroxylation of proline and lysine residues. The pro-alpha chains are subsequently glycosylated and disulfide bonds formed, and then the chains are assembled into the triple helix characteristic of mature collagen. Finally, these collagen molecules are proteolytically cleaved to form fibrillar collagens [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32378/abstract/116\">",
"     116",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In normal lungs, collagen is produced and degraded continuously; this process is tightly regulated to preserve the normal lung structure. Lung fibroblasts synthesize type I and II collagens and may degrade as much as 40 percent of all newly synthesized collagen [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32378/abstract/117,118\">",
"     117,118",
"    </a>",
"    ]. The initial degradation process is accomplished intracellularly, and may take less than 15 minutes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32378/abstract/113\">",
"     113",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Collagen is also degraded extracellularly by a family of matrix metalloproteinases (MMPs) that includes collagenases [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32378/abstract/119\">",
"     119",
"    </a>",
"    ]. Fibroblasts, epithelial cells, neutrophils, and macrophages all secrete these MMPs. The final amount of collagen that is deposited in the lung results from the balance between the processes of synthesis and degradation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h2\">",
"     Idiopathic pulmonary fibrosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;In lungs from patients with IPF, excess collagen is deposited in the extracellular matrix; collagen type I predominates in areas of mature fibrosis, while collagen type III is the predominant type in areas of early fibrosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32378/abstract/31,116,120-122\">",
"     31,116,120-122",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Immunostaining and in situ hybridization techniques have demonstrated an increased number of collagen-synthesizing fibroblasts in the lungs of patients with IPF [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32378/abstract/30,31,56\">",
"     30,31,56",
"    </a>",
"    ]. These fibroblasts, found in clusters, form the characteristic fibrotic foci located in the subepithelial areas of injured lung. These foci are surrounded by residual areas of basal lamina, indicating that they are located on the airspace side of the injured alveoli. In lungs of patients with IPF, but not in normal controls, these sites contain fibroblasts synthesizing collagen [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32378/abstract/121\">",
"     121",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Conflicting data have been obtained regarding the source of increased collagen deposition in pulmonary fibrosis. Increased numbers of collagen-synthesizing cells and increased collagen production have been noted in lung biopsies from patients with IPF [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32378/abstract/122\">",
"     122",
"    </a>",
"    ]. However, fibroblasts isolated from the lungs of patients with IPF and systemic sclerosis were found to synthesize a similar amount of collagen compared with control cell lines, although the rate of collagen degradation was less [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32378/abstract/123,124\">",
"     123,124",
"    </a>",
"    ]. Observations evaluating the expression of collagen type I and procollagen type I mRNA using in situ hybridization have helped to reconcile these observations, demonstrating increased expression of type I collagen within fibroblast foci, without evidence of increased type I procollagen mRNA expression in other areas [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32378/abstract/56\">",
"     56",
"    </a>",
"    ]. Therefore, it appears that the widely variable collagen secretion observed in IPF could be due to a focal, rather than a generalized, increase in fibroblast activation.",
"   </p>",
"   <p>",
"    In addition to increased synthesis and deposition of collagen, decreased collagenolytic activity could theoretically contribute to excess collagen deposition in IPF [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32378/abstract/125\">",
"     125",
"    </a>",
"    ]. By analogy, human gingival fibroblasts isolated from fibrotic lesions appear to have a decreased phagocytic activity (for collagen) compared with those isolated from normal gingiva [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32378/abstract/126\">",
"     126",
"    </a>",
"    ]. However, enhanced collagenase activity has been reported in other fibrotic lung diseases such as sarcoidosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32378/abstract/113\">",
"     113",
"    </a>",
"    ]. Further studies are necessary to clarify the role of collagen degradation in the pathogenesis of IPF.",
"   </p>",
"   <p>",
"    While improved understanding of the distribution and composition of collagen in the fibrotic lung has led to insights in the pathobiology of IPF, there is no convincing evidence to date to support use of biomarkers of collagen metabolism for routine clinical use or therapeutic interventions. Future studies are warranted to investigate the potential of using biomarkers, reflecting the knowledge about collagen subtypes and other proteins or the synthesis and degradation of these proteins in patients with IPF.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h1\">",
"     IMPLICATIONS FOR PROGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The definitions of IPF and UIP, as well as the classification of other idiopathic interstitial pneumonias (IIPs), have been clarified by international experts in Consensus Statements published by the Joint American Thoracic Society and European Respiratory Society [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32378/abstract/127\">",
"     127",
"    </a>",
"    ]. Using this framework, pulmonary pathologists, radiologists, and physicians have improved their ability to classify distinct IIPs accurately, based upon both histological and clinical grounds.",
"    <span class=\"nowrap\">",
"     IPF/UIP",
"    </span>",
"    can now be diagnosed with greater accuracy, and can be more effectively separated from other IIPs. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?4/23/4474?source=see_link\">",
"     \"Idiopathic interstitial pneumonias: Clinical manifestations and pathology\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In addition, increasing effort has focused on histopathologic subclassification of IPF, and the potential implications of these subclasses with respect to patient survival [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32378/abstract/4,6,127,128\">",
"     4,6,127,128",
"    </a>",
"    ]. The following histological variables have been assessed:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Interstitial fibrosis",
"     </li>",
"     <li>",
"      Interstitial cellularity",
"     </li>",
"     <li>",
"      Alveolar cellularity",
"     </li>",
"     <li>",
"      Deposition of young connective and granulation tissue in the small airways and alveoli",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    As an example, it is possible to perform detailed scoring of individual histopathologic features and correlate the results with outcomes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32378/abstract/129\">",
"     129",
"    </a>",
"    ]. In some (but not all) series, a high profusion of fibroblastic foci has been a marker for an increased risk of subsequent mortality [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32378/abstract/129-132\">",
"     129-132",
"    </a>",
"    ]. A higher profusion of fibroblastic foci has also been associated with a decline in forced vital capacity (FVC) and diffusion capacity for carbon monoxide (DLCO) over 6 and 12 months of follow-up [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32378/abstract/131\">",
"     131",
"    </a>",
"    ]. Although agreement is reasonable between various scoring systems for fibroblastic foci and between pathologists with expertise in lung histopathology, the agreement between community pathologists is likely to be lower and the utility of detailed scoring systems in the clinical management of patients with IPF has not been evaluated [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32378/abstract/131,133\">",
"     131,133",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h1\">",
"     IMPLICATIONS FOR TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;IPF is now best conceptualized as a predominantly fibrotic disease that likely results from recurrent injury to the alveolar epithelium; once initiated, the abnormal fibrotic response to injury extends from the epithelium to the interstitial space. The identity and nature of the stimuli that trigger the initiating process in IPF are not understood, and in most cases cannot be recognized because patients generally seek help after the onset of symptoms, when the fibrotic process is already well established.",
"   </p>",
"   <p>",
"    This inability to identify the initiating inflammatory process in human IPF (if there is one) may explain the failure of traditional antiinflammatory modalities, such as glucocorticoids and immunosuppressive agents [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32378/abstract/1,134,135\">",
"     1,134,135",
"    </a>",
"    ]. As noted above, there is usually little or no evidence of inflammation at the time of diagnosis, which is when these agents have been used. As a result, it is not surprising that treatment with antiinflammatory and immunosuppressive agents has been largely ineffective. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?33/60/34762?source=see_link\">",
"     \"Treatment of idiopathic pulmonary fibrosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    With increasing recognition of the pathogenic role of fibroblast proliferation and fibrotic foci, treatment strategies have shifted towards antifibrotic agents. The rationale for the use of these agents rests upon the large amount of basic science data demonstrating an imbalance of cytokines, increased fibroblast proliferation, and excessive extracellular matrix deposition in the lungs of IPF patients. It is hoped that antifibrotic agents (eg,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?30/26/31141?source=see_link\">",
"     pirfenidone",
"    </a>",
"    , monoclonal antibodies against profibrogenic cytokines, inhibitors of TGF-&beta;1, regulators of microRNAs) can interrupt the fibrotic process after it has been initiated and can improve outcomes for patients with IPF. Several clinical trials of these agents are underway (",
"    <a class=\"external\" href=\"file://clinicaltrials.gov/\">",
"     Clinicaltrials.gov",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32378/abstract/136,137\">",
"     136,137",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?33/60/34762?source=see_link&amp;anchor=H23#H23\">",
"     \"Treatment of idiopathic pulmonary fibrosis\", section on 'Pirfenidone'",
"    </a>",
"    .).",
"   </p>",
"   <p>",
"    The observation that the lungs in patients with IPF are glutathione deficient has led to studies of N-acetylcysteine (NAC), an antioxidant precursor of glutathione that has antifibrotic properties in vitro [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32378/abstract/138\">",
"     138",
"    </a>",
"    ]. A multicenter trial found that the combination of NAC, prednisone, and azathioprine resulted in better preservation of lung function than prednisone and azathioprine [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32378/abstract/139\">",
"     139",
"    </a>",
"    ]. However, this triple combination has been found to be harmful compared to placebo in a clinical trial [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32378/abstract/140\">",
"     140",
"    </a>",
"    ]. Whether NAC alone improves outcomes compared with placebo is still under investigation. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?33/60/34762?source=see_link\">",
"     \"Treatment of idiopathic pulmonary fibrosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Disordered coagulation and fibrinolysis may also be important in the pathogenesis of IPF and acute exacerbations of IPF, although the effectiveness of anticoagulation therapies remains unclear [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/39/32378/abstract/141,142\">",
"     141,142",
"    </a>",
"    ]. Attention is also being directed at ways to prevent lung injury and thereby prevent further fibrosis. One hypothesis is that abnormal gastroesophageal reflux may contribute to lung injury and that prevention of microaspiration through adequate control of reflux may decrease the rate of progression of fibrosis. Further research is needed to evaluate this hypothesis. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?33/60/34762?source=see_link&amp;anchor=H34#H34\">",
"     \"Treatment of idiopathic pulmonary fibrosis\", section on 'Future directions'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topic (see",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?7/31/7666?source=see_link\">",
"       \"Patient information: Idiopathic pulmonary fibrosis (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Idiopathic pulmonary fibrosis (IPF), previously known as cryptogenic fibrosing alveolitis (CFA) in Europe, is a chronic, relentlessly progressive fibrotic disorder of the lower respiratory tract that typically affects adults over age 40. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      While the specific cause of IPF is unknown, certain risk factors are associated with IPF, including cigarette smoking, environmental pollutants, and chronic microaspiration. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Initiation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Several mutations have been identified in patients with familial pulmonary fibrosis, including mutations in surfactant proteins, gel-forming mucin, and telomerase. Some of these have also been identified in individuals with sporadic IPF, suggesting a possible genetic predisposition to IPF. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Genetic predisposition'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      It is unclear whether inflammation (which resolves prior to clinical presentation of the patient) is the inciting stimulus in IPF, or whether aberrant epithelial cell and fibroblast responses to nonspecific injury cause the fibrotic response in the absence of inflammation. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Initiation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The mechanism of progressive fibrosis in IPF remains elusive; however a number of likely contributors have been identified (",
"      <a class=\"graphic graphic_figure graphicRef64611 \" href=\"mobipreview.htm?6/32/6662\">",
"       figure 1",
"      </a>",
"      ). It is possible that multiple microinjuries to alveolar epithelial cells induce a fibrotic environment, and that growth factors secreted by the injured epithelial cells activate and recruit fibroblasts. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Mechanisms of fibrosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Following the induction of fibroblast activation, proliferation and differentiation by epithelial injury, fibroblasts and myofibroblasts organize into fibrotic foci; the appearance of fibrotic foci precedes the development of end-stage fibrosis. The evolution of this process is mediated by a variety of growth factors. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Mechanisms of fibrosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In IPF, excess collagen is deposited in the extracellular matrix around fibrotic foci by fibroblasts and myofibroblasts. Collagen type III is the predominant form of collagen in areas of early fibrosis, while collagen type I predominates in areas of mature fibrosis. (See",
"      <a class=\"local\" href=\"#H21\">",
"       'Collagen deposition'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Since several pathways are likely to be contributing to the pathogenesis of pulmonary fibrosis, effective therapy may require a combination of therapeutic strategies. Potential preventive measures that will decrease or halt progression of fibrosis need to be explored. (See",
"      <a class=\"local\" href=\"#H25\">",
"       'Implications for treatment'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32378/abstract/1\">",
"      Raghu G, Collard HR, Egan JJ, et al. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 2011; 183:788.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32378/abstract/2\">",
"      Navaratnam V, Fleming KM, West J, et al. The rising incidence of idiopathic pulmonary fibrosis in the U.K. Thorax 2011; 66:462.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32378/abstract/3\">",
"      Gross TJ, Hunninghake GW. Idiopathic pulmonary fibrosis. N Engl J Med 2001; 345:517.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32378/abstract/4\">",
"      Katzenstein AL, Myers JL. Idiopathic pulmonary fibrosis: clinical relevance of pathologic classification. Am J Respir Crit Care Med 1998; 157:1301.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32378/abstract/5\">",
"      Homer RJ, Elias JA, Lee CG, Herzog E. Modern concepts on the role of inflammation in pulmonary fibrosis. Arch Pathol Lab Med 2011; 135:780.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32378/abstract/6\">",
"      Flaherty KR, Travis WD, Colby TV, et al. Histopathologic variability in usual and nonspecific interstitial pneumonias. Am J Respir Crit Care Med 2001; 164:1722.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32378/abstract/7\">",
"      Cool CD, Groshong SD, Rai PR, et al. Fibroblast foci are not discrete sites of lung injury or repair: the fibroblast reticulum. Am J Respir Crit Care Med 2006; 174:654.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32378/abstract/8\">",
"      Xu YD, Hua J, Mui A, et al. Release of biologically active TGF-beta1 by alveolar epithelial cells results in pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol 2003; 285:L527.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32378/abstract/9\">",
"      Degryse AL, Lawson WE. Progress toward improving animal models for idiopathic pulmonary fibrosis. Am J Med Sci 2011; 341:444.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32378/abstract/10\">",
"      Marshall RP, McAnulty RJ, Laurent GJ. The pathogenesis of pulmonary fibrosis: is there a fibrosis gene? Int J Biochem Cell Biol 1997; 29:107.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32378/abstract/11\">",
"      Naik PK, Moore BB. Viral infection and aging as cofactors for the development of pulmonary fibrosis. Expert Rev Respir Med 2010; 4:759.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32378/abstract/12\">",
"      American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS). Am J Respir Crit Care Med 2000; 161:646.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32378/abstract/13\">",
"      Talbot-Smith A, Syn WK, MacQuillan G, et al. Familial idiopathic pulmonary fibrosis in association with bone marrow hypoplasia and hepatic nodular regenerative hyperplasia: a new \"trimorphic\" syndrome. Thorax 2009; 64:440.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32378/abstract/14\">",
"      Crossno PF, Polosukhin VV, Blackwell TS, et al. Identification of early interstitial lung disease in an individual with genetic variations in ABCA3 and SFTPC. Chest 2010; 137:969.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32378/abstract/15\">",
"      Schwartz D, Collins F. Medicine. Environmental biology and human disease. Science 2007; 316:695.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32378/abstract/16\">",
"      Wang Y, Kuan PJ, Xing C, et al. Genetic defects in surfactant protein A2 are associated with pulmonary fibrosis and lung cancer. Am J Hum Genet 2009; 84:52.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32378/abstract/17\">",
"      Lawson WE, Grant SW, Ambrosini V, et al. Genetic mutations in surfactant protein C are a rare cause of sporadic cases of IPF. Thorax 2004; 59:977.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32378/abstract/18\">",
"      van Moorsel CH, van Oosterhout MF, Barlo NP, et al. Surfactant protein C mutations are the basis of a significant portion of adult familial pulmonary fibrosis in a dutch cohort. Am J Respir Crit Care Med 2010; 182:1419.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32378/abstract/19\">",
"      Bullard JE, Nogee LM. Heterozygosity for ABCA3 mutations modifies the severity of lung disease associated with a surfactant protein C gene (SFTPC) mutation. Pediatr Res 2007; 62:176.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32378/abstract/20\">",
"      Seibold MA, Wise AL, Speer MC, et al. A common MUC5B promoter polymorphism and pulmonary fibrosis. N Engl J Med 2011; 364:1503.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32378/abstract/21\">",
"      Armanios MY, Chen JJ, Cogan JD, et al. Telomerase mutations in families with idiopathic pulmonary fibrosis. N Engl J Med 2007; 356:1317.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32378/abstract/22\">",
"      Tsakiri KD, Cronkhite JT, Kuan PJ, et al. Adult-onset pulmonary fibrosis caused by mutations in telomerase. Proc Natl Acad Sci U S A 2007; 104:7552.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32378/abstract/23\">",
"      Cronkhite JT, Xing C, Raghu G, et al. Telomere shortening in familial and sporadic pulmonary fibrosis. Am J Respir Crit Care Med 2008; 178:729.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32378/abstract/24\">",
"      Alder JK, Chen JJ, Lancaster L, et al. Short telomeres are a risk factor for idiopathic pulmonary fibrosis. Proc Natl Acad Sci U S A 2008; 105:13051.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32378/abstract/25\">",
"      El-Chemaly S, Ziegler SG, Calado RT, et al. Natural history of pulmonary fibrosis in two subjects with the same telomerase mutation. Chest 2011; 139:1203.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32378/abstract/26\">",
"      Snider GL. Interstitial pulmonary fibrosis. Chest 1986; 89:115S.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32378/abstract/27\">",
"      Reynolds HY, Fulmer JD, Kazmierowski JA, et al. Analysis of cellular and protein content of broncho-alveolar lavage fluid from patients with idiopathic pulmonary fibrosis and chronic hypersensitivity pneumonitis. J Clin Invest 1977; 59:165.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32378/abstract/28\">",
"      Bitterman PB, Rennard SI, Keogh BA, et al. Familial idiopathic pulmonary fibrosis. Evidence of lung inflammation in unaffected family members. N Engl J Med 1986; 314:1343.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32378/abstract/29\">",
"      Selman M, King TE, Pardo A, et al. Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy. Ann Intern Med 2001; 134:136.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32378/abstract/30\">",
"      Kuhn C 3rd, Boldt J, King TE Jr, et al. An immunohistochemical study of architectural remodeling and connective tissue synthesis in pulmonary fibrosis. Am Rev Respir Dis 1989; 140:1693.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32378/abstract/31\">",
"      Raghu G, Striker LJ, Hudson LD, Striker GE. Extracellular matrix in normal and fibrotic human lungs. Am Rev Respir Dis 1985; 131:281.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32378/abstract/32\">",
"      Hecker L, Thannickal VJ. Nonresolving fibrotic disorders: idiopathic pulmonary fibrosis as a paradigm of impaired tissue regeneration. Am J Med Sci 2011; 341:431.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32378/abstract/33\">",
"      Hunninghake GW. Antioxidant therapy for idiopathic pulmonary fibrosis. N Engl J Med 2005; 353:2285.",
"     </a>",
"    </li>",
"    <li>",
"     Riches DW, Worthen GS, Augustin A, et al. Inflammation in the pathogenesis of interstitial lung disease. In: Interstitial Lung Disease, 4th ed, King TE Jr, Schwarz MI (Eds), BC Decker, Hamilton, ON, Canada 2003. p.187.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32378/abstract/35\">",
"      Doherty DE, Hirose N, Zagarella L, Cherniack RM. Prolonged monocyte accumulation in the lung during bleomycin-induced pulmonary fibrosis. A noninvasive assessment of monocyte kinetics by scintigraphy. Lab Invest 1992; 66:231.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32378/abstract/36\">",
"      Fries KM, Blieden T, Looney RJ, et al. Evidence of fibroblast heterogeneity and the role of fibroblast subpopulations in fibrosis. Clin Immunol Immunopathol 1994; 72:283.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32378/abstract/37\">",
"      Haslett C, Shen AS, Feldsien DC, et al. 111Indium-labeled neutrophil migration into the lungs of bleomycin-treated rabbits assessed noninvasively by external scintigraphy. Am Rev Respir Dis 1989; 140:756.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32378/abstract/38\">",
"      Burns AR, Smith CW, Walker DC. Unique structural features that influence neutrophil emigration into the lung. Physiol Rev 2003; 83:309.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32378/abstract/39\">",
"      Basset F, Ferrans VJ, Soler P, et al. Intraluminal fibrosis in interstitial lung disorders. Am J Pathol 1986; 122:443.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32378/abstract/40\">",
"      Crapo JD, Barry BE, Gehr P, et al. Cell number and cell characteristics of the normal human lung. Am Rev Respir Dis 1982; 126:332.",
"     </a>",
"    </li>",
"    <li>",
"     Mason RJ, Shannon JM. Alveolar type II cells. In: The Lung: Scientific Foundations, 2nd ed, Crystal RG, West JB, Weibel ER, Barnes PF (Eds), Lippincott-Raven, Philadelphia 1997. p.543.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32378/abstract/42\">",
"      Gabbiani G. Evolution and clinical implications of the myofibroblast concept. Cardiovasc Res 1998; 38:545.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32378/abstract/43\">",
"      Khalil N, Xu YD, O'Connor R, Duronio V. Proliferation of pulmonary interstitial fibroblasts is mediated by transforming growth factor-beta1-induced release of extracellular fibroblast growth factor-2 and phosphorylation of p38 MAPK and JNK. J Biol Chem 2005; 280:43000.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32378/abstract/44\">",
"      Kuroki Y, Takahashi H, Chiba H, Akino T. Surfactant proteins A and D: disease markers. Biochim Biophys Acta 1998; 1408:334.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32378/abstract/45\">",
"      Yokoyama A, Kondo K, Nakajima M, et al. Prognostic value of circulating KL-6 in idiopathic pulmonary fibrosis. Respirology 2006; 11:164.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32378/abstract/46\">",
"      Jenkins G, Blanchard A, Borok Z, et al. In search of the fibrotic epithelial cell: opportunities for a collaborative network. Thorax 2012; 67:179.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32378/abstract/47\">",
"      K&ouml;nigshoff M, Kramer M, Balsara N, et al. WNT1-inducible signaling protein-1 mediates pulmonary fibrosis in mice and is upregulated in humans with idiopathic pulmonary fibrosis. J Clin Invest 2009; 119:772.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32378/abstract/48\">",
"      Chilosi M, Poletti V, Zam&ograve; A, et al. Aberrant Wnt/beta-catenin pathway activation in idiopathic pulmonary fibrosis. Am J Pathol 2003; 162:1495.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32378/abstract/49\">",
"      Garcia CK. Idiopathic pulmonary fibrosis: update on genetic discoveries. Proc Am Thorac Soc 2011; 8:158.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32378/abstract/50\">",
"      Center DM, Berman JS, Kornfeld H, et al. Mechanisms of lymphocyte accumulation in pulmonary disease. Chest 1993; 103:88S.",
"     </a>",
"    </li>",
"    <li>",
"     Martin, TR. Overview of cytokine networks in lung injury. In: American Thoracic Society Continuing Education Monograph Series: \"Cytokines and Pulmonary Infection,\" Pratter, MR, Nelson, S (eds) 1997. p. 19.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32378/abstract/52\">",
"      Wynn TA. Integrating mechanisms of pulmonary fibrosis. J Exp Med 2011; 208:1339.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32378/abstract/53\">",
"      Brody AR. Occupational lung disease and the role of peptide growth factors. Curr Opin Pulm Med 1997; 3:203.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32378/abstract/54\">",
"      Khalil N, O'Connor RN, Flanders KC, Unruh H. TGF-beta 1, but not TGF-beta 2 or TGF-beta 3, is differentially present in epithelial cells of advanced pulmonary fibrosis: an immunohistochemical study. Am J Respir Cell Mol Biol 1996; 14:131.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32378/abstract/55\">",
"      Salez F, Gosset P, Copin MC, et al. Transforming growth factor-beta1 in sarcoidosis. Eur Respir J 1998; 12:913.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32378/abstract/56\">",
"      Broekelmann TJ, Limper AH, Colby TV, McDonald JA. Transforming growth factor beta 1 is present at sites of extracellular matrix gene expression in human pulmonary fibrosis. Proc Natl Acad Sci U S A 1991; 88:6642.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32378/abstract/57\">",
"      Shi-Wen X, Leask A, Abraham D. Regulation and function of connective tissue growth factor/CCN2 in tissue repair, scarring and fibrosis. Cytokine Growth Factor Rev 2008; 19:133.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32378/abstract/58\">",
"      Atamas SP, White B. Cytokine regulation of pulmonary fibrosis in scleroderma. Cytokine Growth Factor Rev 2003; 14:537.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32378/abstract/59\">",
"      Sime PJ, Marr RA, Gauldie D, et al. Transfer of tumor necrosis factor-alpha to rat lung induces severe pulmonary inflammation and patchy interstitial fibrogenesis with induction of transforming growth factor-beta1 and myofibroblasts. Am J Pathol 1998; 153:825.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32378/abstract/60\">",
"      Ortiz LA, Lasky J, Lungarella G, et al. Upregulation of the p75 but not the p55 TNF-alpha receptor mRNA after silica and bleomycin exposure and protection from lung injury in double receptor knockout mice. Am J Respir Cell Mol Biol 1999; 20:825.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32378/abstract/61\">",
"      Whyte M, Hubbard R, Meliconi R, et al. Increased risk of fibrosing alveolitis associated with interleukin-1 receptor antagonist and tumor necrosis factor-alpha gene polymorphisms. Am J Respir Crit Care Med 2000; 162:755.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32378/abstract/62\">",
"      Strieter RM, Keane MP. Innate immunity dictates cytokine polarization relevant to the development of pulmonary fibrosis. J Clin Invest 2004; 114:165.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32378/abstract/63\">",
"      Jiang D, Liang J, Hodge J, et al. Regulation of pulmonary fibrosis by chemokine receptor CXCR3. J Clin Invest 2004; 114:291.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32378/abstract/64\">",
"      Eickelberg O, Pansky A, Koehler E, et al. Molecular mechanisms of TGF-(beta) antagonism by interferon (gamma) and cyclosporine A in lung fibroblasts. FASEB J 2001; 15:797.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32378/abstract/65\">",
"      Ziesche R, Hofbauer E, Wittmann K, et al. A preliminary study of long-term treatment with interferon gamma-1b and low-dose prednisolone in patients with idiopathic pulmonary fibrosis. N Engl J Med 1999; 341:1264.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32378/abstract/66\">",
"      Raghu G, Brown KK, Bradford WZ, et al. A placebo-controlled trial of interferon gamma-1b in patients with idiopathic pulmonary fibrosis. N Engl J Med 2004; 350:125.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32378/abstract/67\">",
"      Eferl R, Hasselblatt P, Rath M, et al. Development of pulmonary fibrosis through a pathway involving the transcription factor Fra-2/AP-1. Proc Natl Acad Sci U S A 2008; 105:10525.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32378/abstract/68\">",
"      Kaminski N, Rosas IO. Gene expression profiling as a window into idiopathic pulmonary fibrosis pathogenesis: can we identify the right target genes? Proc Am Thorac Soc 2006; 3:339.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32378/abstract/69\">",
"      Selman M, Pardo A, Kaminski N. Idiopathic pulmonary fibrosis: aberrant recapitulation of developmental programs? PLoS Med 2008; 5:e62.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32378/abstract/70\">",
"      Kaminski N. Microarray analysis of idiopathic pulmonary fibrosis. Am J Respir Cell Mol Biol 2003; 29:S32.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32378/abstract/71\">",
"      Boon K, Bailey NW, Yang J, et al. Molecular phenotypes distinguish patients with relatively stable from progressive idiopathic pulmonary fibrosis (IPF). PLoS One 2009; 4:e5134.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32378/abstract/72\">",
"      Konishi K, Gibson KF, Lindell KO, et al. Gene expression profiles of acute exacerbations of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2009; 180:167.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32378/abstract/73\">",
"      Rosas IO, Richards TJ, Konishi K, et al. MMP1 and MMP7 as potential peripheral blood biomarkers in idiopathic pulmonary fibrosis. PLoS Med 2008; 5:e93.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32378/abstract/74\">",
"      Wynes MW, Frankel SK, Riches DW. IL-4-induced macrophage-derived IGF-I protects myofibroblasts from apoptosis following growth factor withdrawal. J Leukoc Biol 2004; 76:1019.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32378/abstract/75\">",
"      Cosgrove GP, Brown KK, Schiemann WP, et al. Pigment epithelium-derived factor in idiopathic pulmonary fibrosis: a role in aberrant angiogenesis. Am J Respir Crit Care Med 2004; 170:242.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32378/abstract/76\">",
"      Zhang K, Rekhter MD, Gordon D, Phan SH. Myofibroblasts and their role in lung collagen gene expression during pulmonary fibrosis. A combined immunohistochemical and in situ hybridization study. Am J Pathol 1994; 145:114.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32378/abstract/77\">",
"      Desmouli&egrave;re A, Geinoz A, Gabbiani F, Gabbiani G. Transforming growth factor-beta 1 induces alpha-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts. J Cell Biol 1993; 122:103.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32378/abstract/78\">",
"      Hecker L, Vittal R, Jones T, et al. NADPH oxidase-4 mediates myofibroblast activation and fibrogenic responses to lung injury. Nat Med 2009; 15:1077.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32378/abstract/79\">",
"      Giri SN, Hyde DM, Hollinger MA. Effect of antibody to transforming growth factor beta on bleomycin induced accumulation of lung collagen in mice. Thorax 1993; 48:959.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32378/abstract/80\">",
"      Nakao A, Fujii M, Matsumura R, et al. Transient gene transfer and expression of Smad7 prevents bleomycin-induced lung fibrosis in mice. J Clin Invest 1999; 104:5.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32378/abstract/81\">",
"      Xaubet A, Marin-Arguedas A, Lario S, et al. Transforming growth factor-beta1 gene polymorphisms are associated with disease progression in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2003; 168:431.",
"     </a>",
"    </li>",
"    <li>",
"     Raghu G, Kavanagh TJ. The human lung fibroblast: a multifaceted target and effector cell. In: Interstitial Pulmonary Diseases, Selman-Lama M, Barrios R (Eds), CRC Press Inc, Boca Raton 1991. p.1.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32378/abstract/83\">",
"      Horowitz JC, Thannickal VJ. Epithelial-mesenchymal interactions in pulmonary fibrosis. Semin Respir Crit Care Med 2006; 27:600.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32378/abstract/84\">",
"      Kapanci Y, Costabella PM, Cerutti P, Assimacopoulos A. Distribution and function of cytoskeletal proteins in lung cells with particular reference to 'contractile interstitial cells'. Methods Achiev Exp Pathol 1979; 9:147.",
"     </a>",
"    </li>",
"    <li>",
"     Tremblay GM, Jordana M, Gauldie J, Sarnstrand B. Fibroblasts as effector cells in fibrosis. In: Pulmonary Fibrosis, Pham SH, Thrall RS (Eds), Marcel Dekker, New York 1995. p.541.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32378/abstract/86\">",
"      Phipps RP, Penney DP, Keng P, et al. Characterization of two major populations of lung fibroblasts: distinguishing morphology and discordant display of Thy 1 and class II MHC. Am J Respir Cell Mol Biol 1989; 1:65.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32378/abstract/87\">",
"      Akamine A, Raghu G, Narayanan AS. Human lung fibroblast subpopulations with different C1q binding and functional properties. Am J Respir Cell Mol Biol 1992; 6:382.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32378/abstract/88\">",
"      Sempowski GD, Derdak S, Phipps RP. Interleukin-4 and interferon-gamma discordantly regulate collagen biosynthesis by functionally distinct lung fibroblast subsets. J Cell Physiol 1996; 167:290.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32378/abstract/89\">",
"      McIntosh JC, Hagood JS, Richardson TL, Simecka JW. Thy1 (+) and (-) lung fibrosis subpopulations in LEW and F344 rats. Eur Respir J 1994; 7:2131.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32378/abstract/90\">",
"      Zhou Y, Hagood JS, Murphy-Ullrich JE. Thy-1 expression regulates the ability of rat lung fibroblasts to activate transforming growth factor-beta in response to fibrogenic stimuli. Am J Pathol 2004; 165:659.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32378/abstract/91\">",
"      Narayanan AS, Lurton J, Raghu G. Distribution of receptors of collagen and globular domains of C1q in human lung fibroblasts. Am J Respir Cell Mol Biol 1997; 17:84.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32378/abstract/92\">",
"      Lurton J, Rose TM, Raghu G, Narayanan AS. Isolation of a gene product expressed by a subpopulation of human lung fibroblasts by differential display. Am J Respir Cell Mol Biol 1999; 20:327.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32378/abstract/93\">",
"      Phillips RJ, Burdick MD, Hong K, et al. Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis. J Clin Invest 2004; 114:438.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32378/abstract/94\">",
"      Quan TE, Cowper S, Wu SP, et al. Circulating fibrocytes: collagen-secreting cells of the peripheral blood. Int J Biochem Cell Biol 2004; 36:598.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32378/abstract/95\">",
"      Lama VN, Phan SH. The extrapulmonary origin of fibroblasts: stem/progenitor cells and beyond. Proc Am Thorac Soc 2006; 3:373.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32378/abstract/96\">",
"      Jordana M, Schulman J, McSharry C, et al. Heterogeneous proliferative characteristics of human adult lung fibroblast lines and clonally derived fibroblasts from control and fibrotic tissue. Am Rev Respir Dis 1988; 137:579.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32378/abstract/97\">",
"      Raghu G, Chen YY, Rusch V, Rabinovitch PS. Differential proliferation of fibroblasts cultured from normal and fibrotic human lungs. Am Rev Respir Dis 1988; 138:703.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32378/abstract/98\">",
"      Wilborn J, Crofford LJ, Burdick MD, et al. Cultured lung fibroblasts isolated from patients with idiopathic pulmonary fibrosis have a diminished capacity to synthesize prostaglandin E2 and to express cyclooxygenase-2. J Clin Invest 1995; 95:1861.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32378/abstract/99\">",
"      Maher TM, Evans IC, Bottoms SE, et al. Diminished prostaglandin E2 contributes to the apoptosis paradox in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2010; 182:73.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32378/abstract/100\">",
"      Katzenstein AL, Myers JL, Mazur MT. Acute interstitial pneumonia. A clinicopathologic, ultrastructural, and cell kinetic study. Am J Surg Pathol 1986; 10:256.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32378/abstract/101\">",
"      Vyalov SL, Gabbiani G, Kapanci Y. Rat alveolar myofibroblasts acquire alpha-smooth muscle actin expression during bleomycin-induced pulmonary fibrosis. Am J Pathol 1993; 143:1754.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32378/abstract/102\">",
"      Adler KB, Low RB, Leslie KO, et al. Contractile cells in normal and fibrotic lung. Lab Invest 1989; 60:473.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32378/abstract/103\">",
"      Iwano M, Plieth D, Danoff TM, et al. Evidence that fibroblasts derive from epithelium during tissue fibrosis. J Clin Invest 2002; 110:341.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32378/abstract/104\">",
"      Kalluri R, Neilson EG. Epithelial-mesenchymal transition and its implications for fibrosis. J Clin Invest 2003; 112:1776.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32378/abstract/105\">",
"      Willis BC, duBois RM, Borok Z. Epithelial origin of myofibroblasts during fibrosis in the lung. Proc Am Thorac Soc 2006; 3:377.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32378/abstract/106\">",
"      Kim KK, Wei Y, Szekeres C, et al. Epithelial cell alpha3beta1 integrin links beta-catenin and Smad signaling to promote myofibroblast formation and pulmonary fibrosis. J Clin Invest 2009; 119:213.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32378/abstract/107\">",
"      Thannickal VJ, Horowitz JC. Evolving concepts of apoptosis in idiopathic pulmonary fibrosis. Proc Am Thorac Soc 2006; 3:350.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32378/abstract/108\">",
"      Zhang HY, Gharaee-Kermani M, Zhang K, et al. Lung fibroblast alpha-smooth muscle actin expression and contractile phenotype in bleomycin-induced pulmonary fibrosis. Am J Pathol 1996; 148:527.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32378/abstract/109\">",
"      Kuhn C, McDonald JA. The roles of the myofibroblast in idiopathic pulmonary fibrosis. Ultrastructural and immunohistochemical features of sites of active extracellular matrix synthesis. Am J Pathol 1991; 138:1257.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32378/abstract/110\">",
"      Li Y, Jiang D, Liang J, et al. Severe lung fibrosis requires an invasive fibroblast phenotype regulated by hyaluronan and CD44. J Exp Med 2011; 208:1459.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32378/abstract/111\">",
"      Mitchell JJ, Woodcock-Mitchell JL, Perry L, et al. In vitro expression of the alpha-smooth muscle actin isoform by rat lung mesenchymal cells: regulation by culture condition and transforming growth factor-beta. Am J Respir Cell Mol Biol 1993; 9:10.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32378/abstract/112\">",
"      Pandit KV, Milosevic J, Kaminski N. MicroRNAs in idiopathic pulmonary fibrosis. Transl Res 2011; 157:191.",
"     </a>",
"    </li>",
"    <li>",
"     McAnulty RJ, Laurent GJ. Collagen and its regulation in pulmonary fibrosis. In: Pulmonary fibrosis, Phan SH, Thrall RS (Eds), Marcel Dekker, New York 1995. p.135.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32378/abstract/114\">",
"      van der Rest M, Garrone R. Collagen family of proteins. FASEB J 1991; 5:2814.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32378/abstract/115\">",
"      Jacenko O, Olsen BR, LuValle P. Organization and regulation of collagen genes. Crit Rev Eukaryot Gene Expr 1991; 1:327.",
"     </a>",
"    </li>",
"    <li>",
"     Byers, PH. Disorders of collagen biosynthesis and structure. In: The Metabolic Basis of Inherited Disease, 7th ed, Scriver CR, Beaudet AL, Sly WS, Valle D (Eds), McGraw-Hill, New York 1995.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32378/abstract/117\">",
"      Rennard SI, Stier LE, Crystal RG. Intracellular degradation of newly synthesized collagen. J Invest Dermatol 1982; 79 Suppl 1:77s.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32378/abstract/118\">",
"      Laurent GJ. Rates of collagen synthesis in lung, skin and muscle obtained in vivo by a simplified method using [3H]proline. Biochem J 1982; 206:535.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32378/abstract/119\">",
"      Birkedal-Hansen H, Moore WG, Bodden MK, et al. Matrix metalloproteinases: a review. Crit Rev Oral Biol Med 1993; 4:197.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32378/abstract/120\">",
"      Kaarteenaho-Wiik R, P&auml;&auml;kk&ouml; P, Herva R, et al. Type I and III collagen protein precursors and mRNA in the developing human lung. J Pathol 2004; 203:567.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32378/abstract/121\">",
"      McDonald, JA, Broekelmann, TJ, Matheke, ML, et al. A monoclonal antibody to the carboxyterminal domain of procollagen type I visualizes collagen-synthesizing fibroblasts. Detection of an altered fibroblast phenotype in lungs of patients with pulmonary fibrosis. J Clin Invest 1986; 78:1237.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32378/abstract/122\">",
"      Bateman ED, Turner-Warwick M, Adelmann-Grill BC. Immunohistochemical study of collagen types in human foetal lung and fibrotic lung disease. Thorax 1981; 36:645.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32378/abstract/123\">",
"      Harrison NK, Argent AC, McAnulty RJ, et al. Collagen synthesis and degradation by systemic sclerosis lung fibroblasts. Responses to transforming growth factor-beta. Chest 1991; 99:71S.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32378/abstract/124\">",
"      Raghu G, Masta S, Meyers D, Narayanan AS. Collagen synthesis by normal and fibrotic human lung fibroblasts and the effect of transforming growth factor-beta. Am Rev Respir Dis 1989; 140:95.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32378/abstract/125\">",
"      Selman M, Monta&ntilde;o M, Ramos C, Chapela R. Concentration, biosynthesis and degradation of collagen in idiopathic pulmonary fibrosis. Thorax 1986; 41:355.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32378/abstract/126\">",
"      McCulloch CA, Knowles GC. Deficiencies in collagen phagocytosis by human fibroblasts in vitro: a mechanism for fibrosis? J Cell Physiol 1993; 155:461.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32378/abstract/127\">",
"      American Thoracic Society, European Respiratory Society. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001. Am J Respir Crit Care Med 2002; 165:277.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32378/abstract/128\">",
"      Travis WD, Matsui K, Moss J, Ferrans VJ. Idiopathic nonspecific interstitial pneumonia: prognostic significance of cellular and fibrosing patterns: survival comparison with usual interstitial pneumonia and desquamative interstitial pneumonia. Am J Surg Pathol 2000; 24:19.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32378/abstract/129\">",
"      Cherniack RM, Colby TV, Flint A, et al. Quantitative assessment of lung pathology in idiopathic pulmonary fibrosis. The BAL Cooperative Group Steering Committee. Am Rev Respir Dis 1991; 144:892.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32378/abstract/130\">",
"      Flaherty KR, Colby TV, Travis WD, et al. Fibroblastic foci in usual interstitial pneumonia: idiopathic versus collagen vascular disease. Am J Respir Crit Care Med 2003; 167:1410.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32378/abstract/131\">",
"      Nicholson AG, Fulford LG, Colby TV, et al. The relationship between individual histologic features and disease progression in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2002; 166:173.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32378/abstract/132\">",
"      Enomoto N, Suda T, Kato M, et al. Quantitative analysis of fibroblastic foci in usual interstitial pneumonia. Chest 2006; 130:22.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32378/abstract/133\">",
"      Flaherty KR, Andrei AC, King TE Jr, et al. Idiopathic interstitial pneumonia: do community and academic physicians agree on diagnosis? Am J Respir Crit Care Med 2007; 175:1054.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32378/abstract/134\">",
"      Davies HR, Richeldi L, Walters EH. Immunomodulatory agents for idiopathic pulmonary fibrosis. Cochrane Database Syst Rev 2003; :CD003134.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32378/abstract/135\">",
"      Khalil N, O'Connor R. Idiopathic pulmonary fibrosis: current understanding of the pathogenesis and the status of treatment. CMAJ 2004; 171:153.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32378/abstract/136\">",
"      Khalil N, Parekh TV, O'Connor R, et al. Regulation of the effects of TGF-beta 1 by activation of latent TGF-beta 1 and differential expression of TGF-beta receptors (T beta R-I and T beta R-II) in idiopathic pulmonary fibrosis. Thorax 2001; 56:907.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32378/abstract/137\">",
"      Raghu G, Johnson WC, Lockhart D, Mageto Y. Treatment of idiopathic pulmonary fibrosis with a new antifibrotic agent, pirfenidone: results of a prospective, open-label Phase II study. Am J Respir Crit Care Med 1999; 159:1061.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32378/abstract/138\">",
"      Behr J, Maier K, Degenkolb B, et al. Antioxidative and clinical effects of high-dose N-acetylcysteine in fibrosing alveolitis. Adjunctive therapy to maintenance immunosuppression. Am J Respir Crit Care Med 1997; 156:1897.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32378/abstract/139\">",
"      Demedts M, Behr J, Buhl R, et al. High-dose acetylcysteine in idiopathic pulmonary fibrosis. N Engl J Med 2005; 353:2229.",
"     </a>",
"    </li>",
"    <li>",
"     NHLBI press release. Commonly used three-drug regimen for idiopathic pulmonary fibrosis found harmful. file://public.nhlbi.nih.gov/newsroom/home/GetPressRelease.aspx?id=2812 (Accessed on October 21, 2011).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32378/abstract/141\">",
"      Idell S. Coagulation, fibrinolysis, and fibrin deposition in acute lung injury. Crit Care Med 2003; 31:S213.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/39/32378/abstract/142\">",
"      Kimura M, Tani K, Miyata J, et al. The significance of cathepsins, thrombin and aminopeptidase in diffuse interstitial lung diseases. J Med Invest 2005; 52:93.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 4300 Version 10.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-61.55.141.10-3C5F28D7A6-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f31_39_32378=[""].join("\n");
var outline_f31_39_32378=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H26\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      HISTOPATHOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      ANIMAL MODELS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      INITIATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Genetic predisposition",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Inflammation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Fibroblast and epithelial cell dysfunction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      PERPETUATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      PROGRESSION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      MECHANISMS OF FIBROSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Altered reepithelialization",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Cytokines, growth factors, and other molecules",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Fibrotic foci",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Mesenchymal cells",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Fibroblast subtypes",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      - Thymocyte 1 antigen subtypes",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      - C1q receptor subtypes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Circulating fibrocytes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Fibroblast proliferation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Myofibroblasts",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      COLLAGEN DEPOSITION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Normal lungs",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      Idiopathic pulmonary fibrosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      IMPLICATIONS FOR PROGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      IMPLICATIONS FOR TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PULM/4300\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PULM/4300|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?28/55/29552\" title=\"diagnostic image 1\">",
"      Fibroblast reticulum",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PULM/4300|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?6/32/6662\" title=\"figure 1\">",
"      Model pathogenesis IPF",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PULM/4300|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?36/33/37398\" title=\"picture 1\">",
"      Histology fibrotic foci",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?22/20/22856?source=related_link\">",
"      Approach to the adult with interstitial lung disease: Clinical evaluation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?16/18/16681?source=related_link\">",
"      Approach to the adult with interstitial lung disease: Diagnostic testing",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?16/5/16472?source=related_link\">",
"      Asbestosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?18/49/19222?source=related_link\">",
"      Classification and clinical manifestations of hypersensitivity pneumonitis (extrinsic allergic alveolitis)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?4/23/4474?source=related_link\">",
"      Idiopathic interstitial pneumonias: Clinical manifestations and pathology",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?7/31/7666?source=related_link\">",
"      Patient information: Idiopathic pulmonary fibrosis (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?33/60/34762?source=related_link\">",
"      Treatment of idiopathic pulmonary fibrosis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f31_39_32379="ATPIII classification";
var content_f31_39_32379=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F70489&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F70489&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Adult treatment panel III classification of LDL, total, and HDL cholesterol",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\" colspan=\"2\">",
"        LDL cholesterol, mg/dL (mmol/L)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &lt;100 (2.58)",
"       </td>",
"       <td>",
"        Optimal",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        100 to 129 (2.58 to 3.33)",
"       </td>",
"       <td>",
"        Near or above optimal",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        130 to 159 (3.36 to 4.11)",
"       </td>",
"       <td>",
"        Borderline high",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        160 to 189 (4.13 to 4.88)",
"       </td>",
"       <td>",
"        High",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &ge;190 (4.91)",
"       </td>",
"       <td>",
"        Very high",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\" colspan=\"2\">",
"        Total cholesterol, mg/dL (mmol/L)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &lt;200 (5.17)",
"       </td>",
"       <td>",
"        Desirable",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        200 to 239 (5.17 to 6.18)",
"       </td>",
"       <td>",
"        Borderline high",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &ge;240 (6.20)",
"       </td>",
"       <td>",
"        High",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\" colspan=\"2\">",
"        HDL cholesterol, mg/dL (mmol/L)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &lt;40 (1.03)",
"       </td>",
"       <td>",
"        Low",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &ge;60 (1.55)",
"       </td>",
"       <td>",
"        High",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Adapted from: Adult Treatment Panel III at file://www.nhlbi.nih.gov/.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f31_39_32379=[""].join("\n");
var outline_f31_39_32379=null;
var title_f31_39_32380="DDx WM";
var content_f31_39_32380=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F82116&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F82116&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Differential diagnosis of Waldenstrom macroglobulinemia",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Entity",
"       </td>",
"       <td class=\"subtitle1\">",
"        Bone marrow biopsy",
"       </td>",
"       <td class=\"subtitle1\">",
"        Monoclonal gammopathy",
"       </td>",
"       <td class=\"subtitle1\">",
"        Additional features",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Waldenstrom macroglobulinemia",
"       </td>",
"       <td>",
"        &ge;10 percent infiltration by lymphoplasmacytic lymphoma",
"       </td>",
"       <td>",
"        Circulating monoclonal IgM of any size",
"       </td>",
"       <td>",
"        Anemia, hepatosplenomegaly, lymphadenopathy, and/or systemic symptoms",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Smoldering Waldenstrom macroglobulinemia",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        <p>",
"         Circulating monoclonal IgM &ge;3.0 g/dL",
"        </p>",
"        <p>",
"         and/or",
"        </p>",
"        <p>",
"         &ge;10 percent infiltration by lymphoplasmacytic lymphoma",
"        </p>",
"       </td>",
"       <td>",
"        No anemia, hepatosplenomegaly, lymphadenopathy, or systemic symptoms felt to be related to underlying lymphoplasmacytic proliferation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        IgM MGUS",
"       </td>",
"       <td>",
"        Minimal or no lymphoplasmacytic infiltration of the bone marrow; overall marrow involvement by such cells should be &lt;10 percent",
"       </td>",
"       <td>",
"        Circulating monoclonal IgM concentration &lt;3.0 g/dL",
"       </td>",
"       <td>",
"        No anemia, hepatosplenomegaly, lymphadenopathy, or systemic symptoms felt to be related to underlying lymphoplasmacytic proliferation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Multiple myeloma",
"       </td>",
"       <td>",
"        Infiltration of plasma cells in the bone marrow",
"       </td>",
"       <td>",
"        IgM myeloma is rare; more commonly monoclonal protein is IgG, IgA, light chains only, or infrequently IgD",
"       </td>",
"       <td>",
"        Hypercalcemia, renal insufficiency, anemia, and bone lesions felt to be related to underlying lymphocyte proliferative disorder",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Chronic lymphocytic leukemia/small lymphocytic lymphoma",
"       </td>",
"       <td>",
"        Bone marrow infiltration with small mature appearing lymphocytes that express CD5; expression of CD20 and surface Ig is dim",
"       </td>",
"       <td>",
"        Monoclonal immunoglobulins can be seen in up to 15 percent",
"       </td>",
"       <td>",
"        Anemia, lymphadenopathy, hepatosplenomegaly, and/or systemic symptoms felt to be related to underlying plasma cell proliferative disorder",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Mantle cell lymphoma",
"       </td>",
"       <td>",
"        Bone marrow infiltration with monomorphous small to medium-sized B lymphocytes that overexpress cyclin D1",
"       </td>",
"       <td>",
"        IgM monoclonal protein may be present",
"       </td>",
"       <td>",
"        t(11;14)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Amyloidosis",
"       </td>",
"       <td>",
"        Apple green birefringence under polarized light after staining with Congo red",
"       </td>",
"       <td>",
"        Usually have an associated monoclonal protein",
"       </td>",
"       <td>",
"        Nephrotic syndrome, restrictive cardiomyopathy, peripheral neuropathy, hepatomegaly, macroglossia, and purpura",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     MGUS: monoclonal gammopathy of undetermined significance.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f31_39_32380=[""].join("\n");
var outline_f31_39_32380=null;
var title_f31_39_32381="Tidal volume airway pressure";
var content_f31_39_32381=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F72036&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F72036&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Pressure-volume curve in ARDS",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 390px; height: 299px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Pressure-volume curve in a patient with acute respiratory distress syndrome (ARDS). The slope of the curve is flat at low and high airway pressures (ie, below the inflection point and above the deflection point). In these areas, increases in airway pressure produce minimal increases in lung volume. Compliance is maximized on the straight part of the curve. The deflection point is defined as the level at which the curve begins to divert from a straight line. Above this threshold, the lung is likely to begin to become overdistended. Mechanical ventilation is considered optimal when it takes place on the straight part of the curve between the inflection and deflection points.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Redrawn from Brunet, F, Jeanbourquin, D, Monchi, M, et al, Am J Respir Crit Care Med 1995; 152:524.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f31_39_32381=[""].join("\n");
var outline_f31_39_32381=null;
var title_f31_39_32382="Fracture identification practice tool";
var content_f31_39_32382=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F65549&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F65549&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 620px\">",
"   <div class=\"ttl\">",
"    Fracture identification practice tool",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 600px; height: 396px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f31_39_32382=[""].join("\n");
var outline_f31_39_32382=null;
var title_f31_39_32383="Rx scleroderma renal crisis";
var content_f31_39_32383=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RHEUM%2F74898&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RHEUM%2F74898&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 552px\">",
"   <div class=\"ttl\">",
"    Algorithm for the management of scleroderma renal disease",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 532px; height: 435px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f31_39_32383=[""].join("\n");
var outline_f31_39_32383=null;
